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ABBREVIATIONS 
°C Degree Celsius 
∞ Forever 
µl Microliter  
µm Micrometre 
µM Micromolar 
% Percent 
    
4-HNE 4-Hydroxynonenal 
AD Alzheimer’s disease 
ADP Adenosine diphosphate 
AGE   Advanced glycation end product  
AKR Aldo keto reduktase 
Ala   Alanine 
ALDH   Aldehyde dehydrogenase 
Aldh3a1 Aldehyde dehydrogenase 3 family, member a1 
ALE Advanced lipoxidation end product 
AMP Adenosine monophosphate 
Amp Ampicillin 
approx. Approximately  
Arg Arginine 
Asn Asparagine 
Asp Aspartate/aspartic acid 
ATP Adenosine triphosphate 
bp Base pairs 
BSA Bovine serum albumin 
Cas9 CRISPR associated protein 9 
CD36 Cluster of differentiation 36 
cDNA Complementary deoxyribonucleic acid 
CL Cardiolipin 
cm Centimetre 
Con Control 
CRISPR Clustered regularly-interspaced short palindromic repeats 
CTGF Connective tissue growth factor 
Cys  Cysteine 
DM Diabetes 
DME Diabetic macular edema 
DLAV Dorsal longitudinal anastomotic vessel 
DKFZ German Cancer Research Center 
DNA Deoxyribonucleic acid 
dpf Days after post fertilization 
DPP4 Dipeptidyl peptidase 4 
DR Diabetic retinopathy 
E. coli Escherichia coli 
EGFP  Enhanced green fluorescent protein 
FFA fluorescein angiography 
fli1 Friend leukemia integration1 
Frc-6-P Fructose-6-phosphate 
g Gram 
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GABA Gamma-aminobutyric acid 
GC-MS Gas chromatography-mass spectrometry 
GDM Gestational diabetes 
Gln Glutamine 
Glo1 Glyoxalase1 
Glp1 Glucagon-like peptide 
Glu Glutamic acid 
Gly Glycine 
GPx Glutathione peroxidase 
gRNA Guide RNA 
GSEA Gene set enrichment analysis 
GSH Glutathione 
GSSG Glutathione disulphide 
GST Glutathione S-transferase 
h Hours 
H2O Histidine 
HbA1C Glycated hemoglobin 
HCE human corneal epithelial cell line 
HIF1 Hypoxia-inducible transcription factor 1 
hpf  Hours after post fertilization 
HPLC High performance liquid chromatography 
Hz Hertz 
Ile Isoleucine 
kb Kilo bases 
KCl Potassium chloride 
l Litre 
IDDM Insulin-dependent diabetes mellitus 
IFG Impaired fasting glycaemia 
IGT Impaired glucose tolerance 
Ins Preproinsulin 
Insb Preproinsulin b 
Isl1 ISL LIM homeobox 1 
Isl2a ISL LIM homeobox 2a 
Isl2b ISL LIM homeobox 2b 
IOC Inner optic circle 
ISV Intersegment vessel 
LB Lysogeny broth 
LC-MS/MS Liquid chromatography-tandem mass spectometry 
LD50 Median lethal dose 
Leu Leucine 
LRP LDL receptor-related protein 
Lys Lysine 
KATP ATP-regulated potassium 
M Molar 
MARD mild age-related diabetes 
MDA malondialdehyde 
Met Methionine 
MG Methylglyoxal 
mg Milligram 
min Minutes 
ml Millilitre 
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mM Millimolar 
Mnx1/Hb9 Motor neuron and pancreas homeobox 1  
MO Morpholino 
MOD mild obesity-related diabetes 
MODY maturity onset diabetes of the young 
Mpc1 Mitochondrial pyruvate carrier 1 
Mpc2 Mitochondrial pyruvate carrier 2 
mRNA Messenger RNA 
MTA Methylthioadenosine 
n  Number of samples 
NAC N-acetyl-cysteine 
NaCl Sodium chloride 
NADH Nicotinamide adenine dinucleotide 
NADPH Nicotinamide adenine dinucleotide phosphate 
NCBI National Center for Biotechnology Information 
NDM Neonatal diabetes mellitus 
NECA 5’-N-ethylcarboxamidoadenosine 
NF Normal feeding 
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells 
nl Nanolitre 
nm Nanometre 
nmol Nanomole 
NO Nitrate Oxygen 
NOX NADPH oxidase 
NSAIDs Non-steroidal anti-inflammatory drugs 
OCT Optical coherence tomography 
OGTT Oral glucose tolerance test 
OF Overfeeding 
Orn Ornithine 
p p-value 
PAM Protospacer adjacent motif 
PAS Periodic acid Schiff 
PBS Phosphate buffered saline 
PCA Principal component analysis 
PCR Polymerase chain reaction 
PD Parkinson’s disease 
PDK4 Pyruvate dehydrogenase lipoamide kinase isozyme 4 
PDH pyruvate dehydrogenase 
PDR Proliferative diabetic retinopathy 
Pdx1 Pancreatic and duodenal homeobox 1 
PFA Paraformaldehyde 
Phe Phenylalanine 
PKC Protein kinase C 
PLC Phospholipase C 
pmol Picomol 
PNDM permanent neonatal diabetes mellitus 
PPAR Peroxisome proliferator-activated receptor 
PP cell Pancreatic polypeptide cell 
Pro Proline 
PTF1A Pancreas transcription factor 1 subunit alpha 
PTU Phenylthiourea 
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RAS Renin angiotensin system 
RFX6 Regulatory factor X, 6 
ROS  Reactive-oxygen species  
RPE Retinal pigmented epithelium  
rpm Rounds per minute 
RT-PCR Reverse transcription polymerase chain reaction 
RT-qPCR Real time-quantitative polymerase chain reaction  
SAM S-adenosyl methionine 
SAID Severe autoimmune diabetes 
SA segmental artery 
SB Splice blocking 
SD Standard deviation 
SDS Sodium dodecyl sulfate 
Ser Serine 
SGLT2 Sodium/glucose cotransporter 2 
SHC S-adenosyl homocysteine 
SIDD Severe insulin-deficient diabetes 
SIRD severe insulin-resistant diabetes 
SV Segmental vein 
T1DM Type 1 diabetes 
T2DM Type 2 diabetes 
TCA Tricarboxylic acid 
Tg Transgenic 
Thr Threonie 
Tris Tris-aminomethan 
Tyr Tyrosine 
UCP2 mitochondrial uncoupling protein 2 
UPLC-FSR Ultra-performance liquid chromatography with fluorescence 
detection 
UV Ultraviolet 
Val Valine 
VEGF Vascular endothelial growth factor 
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1 INTRODUCTION 
 Diabetes mellitus (DM). 
 
Diabetes mellitus (DM) is a group of metabolic disorders characterized by high blood 
glucose levels 1. Over recent years the global prevalence of diabetes was increasing 
rapidly2, according to the IDF DIABETES ATLAS 9th edition, by approximately 463 
million people in 2019 and was expected to 700 million in 20453. In the meantime, the 
number of deaths resulting from diabetes and its complications is estimated to be 4.2 
million, and annual global health expenditure on diabetes treatment including its 
complications is estimated to be USD 760 billion in 2019. 
 
Currently, there are three main types of diabetes: Type 1 diabetes(T1DM), type 2 
diabetes(T2DM) and gestational diabetes (GDM), which is more like a temporary 
status in pregnant women that carries long-term risk of T2DM4.  Results from the failure 
of pancreas and β cells, T1DM is an autoimmune dysfunction by insufficient/absolute 
insulin secretion in the body 5. Referred to as "insulin-dependent diabetes mellitus" 
(IDDM) or "juvenile diabetes"6, patients with T1DM require insulin therapy every day to 
regulate their blood glucose level. T2DM, making up the majority of diabetic patients 
worldwide, results from insulin resistance with relative insulin deficiency to an 
extensive secretory defect7. T2DM is often diagnosed after the occurrence of late 
complications and accompanied with other disorders such as metabolic syndrome8. 
Furthermore, due to the high heterogeneity of T2DM, a refined classification of 
Diabetes was identified as five subgroups: severe autoimmune diabetes (SAID), 
severe insulin-deficient diabetes (SIDD), severe insulin-resistant diabetes (SIRD), mild 
obesity-related diabetes (MOD), mild age-related diabetes (MARD) 9. This new sub 
stratification could help to tailor and target early treatment to patients and may 
represent a primary step towards precision medicine in diabetes. 
Besides, one of several single-gene mutations can also cause destruction of β cell and 
lead to Diabetes, including neonatal diabetes mellitus (NDM) and maturity onset 
diabetes of the young(MODY). Apart from diabetes, impaired glucose tolerance (IGT) 
and impaired fasting glycaemia (IFG) are pre-diabetic states and intermediate 
conditions between normal blood glucose and hyperglycaemia. As IGT and IFG are 
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curable disease states and often considered the precursors for T2DM, appropriate 
diagnose and lifestyle management are essential to enhance diabetes prevention10.  
 
Insulin is the hormone to regulate glucose uptake from the blood into most cells of the 
body 11. Hence, insulin secretion deficiency or insulin resistance plays a central role in 
all types of DM. Insulin is released into the blood by beta cells (β cells) from pancreas 
islet in the response of glucose alternation in the body 12. In the normal physiological 
condition, elevated internal glucose level, especially after eating, will promote the 
secretion of insulin. Then two-third of the cells will absorb the glucose as energy 
substrate via insulin usage. To the contrary, lower glucose levels will reduce the 
secretion and elevate the glucagon amount, which is produced by alpha cells of the 
pancreas and convert the stored glycogen into glucose13. When the secretion of insulin 
is insufficient, or cells respond poorly because of insulin resistance, the glucose cannot 
enter into cells properly, and the blood sugar level remains high 14.  
  
As diabetes is characterized by recurrent or persistent hyperglycaemia, the diagnose 
criteria is based on the blood sugar level by any one of the following: Fasting plasma 
glucose level ≥ 7.0 mmol/L (126 mg/dL), plasma glucose ≥ 11.1 mmol/L (200 mg/dL) 
two hours after a 75 gram oral glucose load as in an oral glucose tolerance test (OGTT) 
and glycated haemoglobin (HbA1C) ≥ 48 mmol/L( ≥6.5%) 15. The basic idea of diabetes 
management is to keep a healthy blood sugar level and avoid causing hypoglycaemia. 
Avoid the high-risk factors, including smoking, hypertension, lack of exercise and keep 
a healthy lifestyle are the preliminary rules for curing diabetes. Further, proper 
medication is necessary for diabetes treatment. In T1DM, exogenous insulin 
administration is necessary, and immunotherapies which will prevent  β cell destruction 
are developing rapidly according to the development of medical technology16. While in 
T2DM, metformin remains the primary option and treatment has been widely 
expanded17, including sulfonylureas, sodium/glucose cotransporter 2 (SGLT2) 
inhibitors, glucagon-like peptide 1 (GLP1) receptor agonists, and dipeptidyl peptidase 
4 (DPP4) inhibitors. Moreover, a medication that has cardiovascular or renal benefits 
should be prescribed, but depends well on the accompanying complications 18.  
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 Chronic diabetic complications and diabetic retinopathy (DR) 
 
The complications of DM include the problems that they develop rapidly (acute) and 
over time (chronic) and may affect several organ systems. Most acute complications 
occur due to the glucose disorders, such as hypoglycaemia, diabetic ketoacidosis and 
hyperosmolar hyperglycaemic non-ketotic coma19. While chronic complications are 
caused by a mixture of microvascular, macrovascular disorders and immune 
dysfunction. Microvascular disorders lead to microangiopathy in several vital organs, 
including brain, heart, kidneys, eyes and nerves, and finally results in diabetic 
nephropathy, neuropathy, retinopathy, cardiomyopathy etc.  
Since 2001, Brownlee proposed a unifying hypothesis which was identified to be 
responsible for the development of complications. The whole hypothesis includes four 
pathways: the polyol pathway, hexosamine pathway, protein kinase C (PKC) pathway 
and the advanced glycation end product (AGE) pathway20. All the above pathways 
lead to the elevation of stress and metabolic imbalances. Several increased reactive 
metabolites during the imbalances, such as O2- and H2O2, accelerate the formation of 
AGE, activate the polyol pathway and phospholipase C(PLC) 21.Consequently, the 
increased accumulation of AGEs sorbitol, oxidative stress and inflammation, while also 
the disregulation of epigenetic genes, resulting in the formation of diabetic tissue and 
microvascular damage22. 
 
Diabetic retinopathy(DR) is a common microvascular complication of diabetics and the 
leading cause of vision loss in working-age people in the world23. Although just one-
third of diabetic patients have the signs of DR and only one-third of DR patients may 
suffer from vision-threatening retinopathy including proliferative DR and diabetic 
macular edema (DME) 24, 25.  The individual lifetime risk of DR is 50–60% in a person 
with T2DM and up to even 90% in T1DM patients 26, 27. Moreover, DR gets fifth place 
among the common causes of blindness or severe vision impairment 28. The quality of 
life may be impaired in patients with severe degrees of DR by reduced physical, 
emotional and social well-being and increased health-care resources29.  
The understanding of the pathophysiological mechanisms of DR is constantly updated 
30, 31. Before the overt microvascular complications, retinal neurodegeneration can take 
place and causing neuronal dysfunction right up to neural apoptosis32 or altered 
neurovascular coupling33. Besides, chronic exposure to hyperglycaemia and other 
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high-risk factors such as hypertension can initiate a cascade of biochemical and 
physiological alternations and finally lead to microvascular damage and retinal 
dysfunction34.  
 
Several biochemical mechanisms have evolved in the modulation of DR 
pathophysiology.  Vascular endothelial growth factor (VEGF) expressed by retinal 
endothelial cells and pericytes can stimulate angiogenesis and increase capillary 
permeability in response to hypoxia. At the meantime, angiotensin II, up regulated in 
diabetes, might also increase VEGF expression in retinal endothelial cells [32]. In 
response to retinal ischaemia, erythropoietin may have neuroprotective effects and act 
independently of VEGF during retinal angiogenesis in proliferative retinopathy 35. 
Besides, hyperglycaemia induces oxidative stress via increased reactive-oxygen 
species (ROS) production, leading to PKC as well as polyol pathway activation and 
AGE formation. They together regulate cell signalling, cell metabolism and angiogenic 
factor expression and result in retinal neurodegeneration and angiogenesis at end36. 
 
The progression of DR pathology can be slow and divide into four overlapping clinical 
stages 25: 1.Retinal damage by microaneurysms formation via a fundoscopic 
examination but without any visible microvascular abnormalities; 2. Mild or moderate 
non-proliferative retinal microvascular; 3. Severe non-proliferative DR; 4.Proliferative 
and advanced stages of DR.   The diagnosis of DR is usually performed by an eye 
examination: visual acuity test, ophthalmoscopy, pupil dilation and some advanced 
tests such as fundus fluorescein angiography (FFA) and optical coherence tomography 
(OCT). With the restriction to patients with Diabetes, a spectrum of retinal 
microvascular lesions is a typical sign for diagnosing 25. 
Within five years of diagnosing, approximately half of the high-risk proliferative diabetic 
retinopathy (PDR) patients will suffer from visual impairments without effective 
treatments37. Optimal control of blood glucose and blood pressure is the foundation 
stone for preventing the progression of DR 25.   Current main medications include 
corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), renin angiotensin 
system (RAS) blockers and surgery. Laser and vitrectomy surgery is sufficient to avoid 
vision loss before retina is severely damaged 38.  Moreover, intravitreal anti-VEGF 
agents have heralded a new treatment paradigm for DME, with the potential to improve 
vision and quality of life39. 
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 Mechanisms of pancreas development in diabetes  
 
The pancreas is composed of two morphologically and functionally distinct 
compartments40: the exocrine compartment, as a part of the digestive system, 
comprises acinar cells and secrets pancreatic juice and digestive enzymes into the 
duodenum through the pancreatic duct; the endocrine compartment, throughout the 
pancreatic parenchyma in functional units known as “islets of Langerhans”41. 
Pancreatic islets include five major types of cells and each cell synthesizes and 
secretes a principle hormone: insulin from β cell s, glucagon from α-cells, somatostatin 
from δ-cells, and pancreatic polypeptide from pancreatic polypeptide (PP) cells and 
ghrelin from ε-cells. Insulin and glucagon are released directly into the circulation to 
regulate blood sugar levels. 
 
β cells, the primary type of cells in endocrine lineage, makeup 50–70% of the cells in 
human islets, synthesize and secrete insulin and amylin and play a central role in 
glucose homeostasis 42. Hence, the reduction of β cell mass or loss of function can 
lead to insufficient insulin secretion and cause diabetes: β cells are lost due to 
autoimmune destruction in T1DM while in T2DM, a developing failure of β cells cannot 
satisfy body’s insulin demand 43. Besides, the disruption of a range of pancreas 
development relevant transcription factors by mutation, such as pancreatic and 
duodenal homeobox 1(PDX1), pancreas transcription factor 1 subunit alpha (PTF1A), 
motor neuron and pancreas homeobox 1 (MNX1) and regulatory factor X, 6 (RFX6), 
can lead to β cell failure and permanent neonatal diabetes mellitus (PNDM)44-49. PNDM 
tends to show low birth weight, permanent inadequate secretion of insulin because of 
the insufficient function of β cells, and the corresponding mutation is supposed as the 
leading cause of monogenic DM. 
 
Unlikely mammalians,  zebrafish can regenerate β cells throughout their entire life50. 
After around seven thousand small molecules screen, Anderson et al. found adenosine 
agonist 5’-N-ethylcarboxamidoadenosine (NECA) can increase β cell proliferation and 
promote the restoration of normal glucose level in zebrafish larvae 51. Delaspre et al. 
illuminated centroacinar cells (Notch-On) contribute to β cell regeneration and 
neogenesis 52. Besides, α cell is also an essential source of β cell regeneration 53. 
Taken together, these studies suggest that appropriate signalling pathway and backup 
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cell systems are essential for β cell regeneration. However, mechanisms for 
mammalian β cell regeneration is still under investigation. As a unique model, 
understanding the specific cues that allow for proper pancreatic and β cell regenerative 
development in zebrafish, can help to accelerate the research progress of diabetes 
diagnoses and therapies.  
 
 4-Hydroxynonenal (4-HNE) and its function in Diabetes. 
 
4-Hydroxynonenal (4-HNE) is an α, β-unsaturated hydroxyalkenal that is produced by 
lipid peroxidation in cells.  Three functional groups, an aldehyde, a double-bond at 
carbon 2, and a hydroxyl group at carbon 454, makes it a very reactive and dangerous 
compound.  
As the most prominent lipid peroxidation specific aldehydes, 4-HNE has drawn 
significant attention during the last 40 years and is known to be a significant aldehyde 
product after the peroxidation of w6 polyunsaturated fatty acids, including linoleic acid 
and arachidonic acid55.If not detoxified by its corresponding enzymes properly, such 
as aldehyde dehydrogenase(ALDH), aldo keto reduktase (AKR) and glutathione S-
transferase (GST), 4-HNE can join in several different chemical reactions with multiple 
targets56. Mostly, 4-HNE can forms 1,4-Michael addition adducts with cysteine, while 
also other two amino acids, histidine and lysine in a lower frequency57.  
 
It is widely known that oxidative stress is a precursor to the elevation of ROS58. Low 
levels of ROS play a fundamental role in redox signalling; on the contrary, elevated 
ROS level, as an oxidative stress marker, reflects the imbalance of the redox system 
and relates to lipid peroxidation59. As the most cytotoxic product generated by lipid 
peroxidation60, 4-HNE is also considered a biomarker of oxidative stress57. 
In normal physiological conditions, the half-life of 4-HNE is just two minutes because 
of the metabolism 61. For example, ALDH isoforms, especially ALDH2 and ALDH3 with 
the highest efficiency of 4-HNE detoxification, can oxidize the carbonyl group of 4-HNE 
to become the production of 4-hydroxynonenoic acid61. The concentration of 4-HNE in 
the cell membranes can be 10 µM to 5 mM in responding to oxidative stress. In 
physiological concentration, it can evoke proliferation, differentiation, compensatory 
mechanisms and unfolded protein response in cells; while in pathological 
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concentration, it can cause damaging effects such as apoptosis, mitochondrial 
dysfunction, inflammation and proteasome dysfunction 62.  
 
Due to the high reactive property, 4-HNE has been associated with several different 
diseases, including but not limited to, Alzheimer’s disease (AD), Parkinson’s disease 
(PD), heart disease, atherosclerosis, cancers and diabetes 61, 63-66. Generally, 4-HNE 
plays a very complicated role in diabetes depending on its concentration: in 
physiological concentration，4-HNE is below the cytotoxic amount and can react to 
high glucose by active peroxisome proliferator-activated receptor d (PPARd) 
complexes, which then induce the transcription and expression of pyruvate 
dehydrogenase lipoamide kinase isozyme 4 (PDK4) and cluster of differentiation 
36(CD36), finally increasing the secretion of insulin in INS-1E beta cells67. When the 
neutralization capacity of 4-HNE is exceeded, it modifies macromolecules structure, 
conformation and function, accompanied with AGEs and advanced lipoxidation end 
products (ALEs)’ elevation, leading to β cell dysfunction at the end 68.  
Additionally, several different studies reported the strong correlation between 4-HNE 
and diabetes complications: G. Liu et al. found 4-HNE was highly present in diabetic 
rat kidneys and led to lipid peroxidative injury 69. The distal axonopathy generated by 
4-HNE treatment mimicked axon pathology observed in neurons isolated from diabetic 
rats 70. Asami Mori et al. showed an intravitreal injection of 4-HNE significantly 
prevented the vasodilation of retinal arterioles and may contribute to the retinal 
vascular dysfunction in DR patients 71. However, studies regarding the “role” of 4-HNE 
in diabetes and if it is related to oxidative stress are still restricted. An appropriate 
model is necessary for next in vivo exploration. 
 
 Aldehyde dehydrogenase (ALDH) superfamily and ALDH3A1. 
 
The aldehyde dehydrogenase (ALDH) superfamily is composed of nicotinamide 
adenine dinucleotide (phosphate) (NAD(P)+)-dependent enzymes which play an 
essential role in detoxifying endogenous and exogenous aldehydes72. These large 
superfamily enzyme systems exist in almost all kind of life forms from bacteria, archaea 
to eukaryotes73, which suggest a vital role goes through evolutionary history. Besides, 
ALDHs have a broad tissue distribution and can be found in all subcellular locations74. 
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Based on the 2002 ALDH superfamily update75, 555 ALDH genes were listed. To date, 
there are 20 functional ALDH genes in the human genome 73 and 21 in zebrafish. 
 
ALDH enzymes belong to oxidoreductases family as responsible for aldehydes 
detoxification. In addition to the capacity of metabolizing aldehydes, ALDH  exhibit 
additional enzymatic and non-enzymatic functions, such as they bind several 
endobiotic and xenobiotic molecules including drugs, hormones etc,  as shown for 
ALDH1A1, ALDH3A1 and ALDH16A174; and as structural elements in the eye 
crystalline, for example ALDH1A1 and ALDH3A1 72. ALDHs are also involved in other 
physiological processes such as regulation of oxidative stress, neurotransmission, cell 
proliferation, differentiation and survival, especially in the biosynthesis of retinoic acids 
76.   
Mutations in ALDH genes can lead to altered ALDH activities and defective aldehyde 
metabolism, which makes individuals vulnerable to aldehyde-related pathogenesis and 
relates to several diseases73, such as cataracts (ALDH1A1, ALDH3A1, ALDH18A1), 
epileptic seizures (ALDH7A1), hyperprolinaemia (ALDH4A1), heart disease (ALDH2), 
alcohol sensitivity (ALDH1A1, ALDH1B1, ALDH2),  cancers (ALDH2) and a wide range 
of other metabolic and developmental abnormalities76. 
 
Aldehyde dehydrogenase 3 families, member A1 (ALDH3A1) is a metabolic enzyme 
that oxidizes mainly toxic lipid peroxidation aldehydes to their corresponding carboxylic 
acids 77. It constitutive in the epithelial layers of lung, stomach, urinary bladder, skin 
and especially in the cornea78.ALDH3A1 is one of the most abundantly expressed 
proteins in the corneal epithelium, accounting for 5 to 50% of the total water-soluble 
protein fraction in mammalian species79. Thus it exerts a variety of antioxidant and 
cytoprotective properties in protecting the cornea during the oxidative stress induced 
by ultraviolet(UV) light, including such five pathways: a. detoxify several toxic 
aldehydes during lipid peroxidation80; b. absorb the UV light directly81; c. antioxidant 
function by scavenging free radicals82; d. regulate the refractive and transparent 
properties of corneal83 and e. chaperone-like activity84. 
Several studies have shown a high ALDH3A1 affinity for 4-HNE but low ability to 
detoxify malondialdehyde (MDA), which also supported its multifaceted function 76, 85, 
86. In rabbit corneal stromal fibroblastic cell line (TRK43), human ALDH3A1 induction 
reduced the toxic potency of 4-HNE (LD50 increased from 25 to 75 μM), decreased 4-
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HNE-protein adduct formation and resulted in less DNA fragmentation occurring at 
higher 4-HNE exposure concentrations87. Besides, ectopic expression of ALDH3A1 
was associated with cell cycle elongation, reduced DNA synthesis and significant 
alteration of major cell cycle regulators 77, 88. 
 
At present few studies have illuminated the role of ALDHs and ALDH3A1 in the disease 
model:  a study in mice showed that ALDH3A1-deficient mice developed cataracts 
because of the proteasome inhibition by lipid peroxidation [86]. However, further 
investigations regarding their regulation function especially in diabetes and cancers 
remain to be essential for disease manifestation, diagnosis and therapy. 
 
 Aim of the thesis. 
 
The increased formation of methylglyoxal (MG) under hyperglycaemia is associated 
with the development of microvascular complications in patients with diabetes 
mellitus89. However, in zebrafish, a permanent knock out of glyoxalase 1(Glo1), the 
main MG detoxifying system, only led to a two-fold elevation of endogenous MG levels. 
Importantly, a two-fold increase in ALDH activity, a group of enzymes which catalyse 
the oxidation of aldehydes and may compensate for the loss of Glo1, was observed. 
Furthermore, qPCR-based expression data identified increased mRNA levels of 
aldh3a1 in the glo1 mutants suggesting Aldh3a1 as an alternative protein for the 
detoxification of reactive metabolites90.  
 
Besides, in the previous period, few studies focused on the antioxidant function of 
ALDH3A1 in the corneal epithelium 79, 85, 88. The function of ALDH3A1 in metabolomics, 
pancreas development, vascular angiogenesis and diabetes with its complications and 
if it is related to the 4-HNE detoxifying ability is still unclear. Moreover, in zebrafish, the 
available data have only reported the existence of the Aldh3a1 enzyme system, but its 
basic function and properties in organ development and disease processes remain 
unknown.  
 
Therefore, the thesis aimed to evaluate the short- and long-term effects of Aldh3a1 
enzyme system on diabetes and its complications via knockdown and knockout 
strategies in vivo by using zebrafish as a model organism. The objective was to 
Introduction 
 14 
generate an Aldh3a1 zebrafish knockout line, to investigate the characteristic of 
metabolic state and morphology alternation of pancreas and vasculature system under 
normal, hyperglycaemia and high nutrition intake conditions. The working hypothesis 
was: 1. Loss of Aldh3a1 enzyme system leads to the dysfunction of 4-HNE 
detoxification in zebrafish. 2. The accumulation of 4-HNE in vivo results in organ 
damage, hyperglycaemia, vascular alterations and metabolomics changes 
subsequently. 
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2 MATERIALS AND METHODS 
If not mentioned otherwise, all materials and methods used during the experiments are 
according to the standard protocols of AG Kroll’s Lab, which may be modified from the 
methods section of the enclosed papers90-92. 
 
 Material 
 
2.1.1 Equipment 
 
Agarose gel chamber    Peqlab Biotechnologie GmbH  
Bench top centrifuge (Rotina 420R)  Hettich  
BioPhotometer D30    Eppendorf  
Dry bath incubator     Major Science 
Electronic balance    Kern & Sohn GmbH  
Electrophoresis power supply   Consort  
Glucometer Freedom Lite   Abbott(FreeStyle) 
Hamilton syringe (Glastight® #1705) Hamilton 
Jun-Air 3-4 Quiet Running Compressor  Jun-Air 
(11 l / min at 8 bar) 
Leica HI1210 water bath   Leica 
Leica RM2235 microtome   Leica 
QuantStudio 3 Real-Time-PCR-System Applied Biosystems  
Microcentrifuge Mikro 200R  Hettich  
PCR cycler     BioRad  
pH-meter ProfiLine 197i   WTW ProfiLine 
See-saw rocker                  Stuart 
Table centrifuge    Carl Roth GmbH 
UV transilluminator    INTAS 
Vertical Micropipette Puller P30  Sutter instruments Co.  
Water Bath                         Seelbach  
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2.1.2 Chemicals  
 
If not indicated otherwise, all chemicals used during the experiments, were purchased 
from the following companies: 
 
Carl Roth GmbH & Co. KG 
Merck AG 
Roche Diagnostics GmbH 
Sigma-Aldrich Chemie GmbH 
Thermo Fisher Scientific Inc.  
 
2.1.3 Consumables  
 
0.22 μm syringe filter                                   Millex 
Blood glucose test stripes Abbott (FreeStyle Lite) 
Conical tubes (15 ml, 50 ml) Falcon 
Dumont Tweezers No. 5 NeoLabs 
Feather disposable scalpel No.10 Feather 
Glass culture cyl. (14 mm I.D. x 5 mm) Biotechs 
Microscope slides (76x26 mm) IDL 
Needle 20G x1 ½” nr.1 BD Microlance 
Nitrile Gloves Semperguard 
Pasteur Pipettes Hirschmann 
PCR tubes (0.2 ml) Star Labs 
Petri dishes (10cm and quadratic) Greiner 
Pipette filter tips (1000, 100, 20 and 10 μl) Nerbe plus GmbH 
Pipette tip refills (1000, 200, 10 μl)  TipOne Star Labs 
Pipettes (P1000, P200, P20 and P2)  Gilson/Eppendorf 
Quantitative PCR 96-well reaction plate Axon 
Safe-Lock tubes (0.5, 1.5 and 2.0 ml) Eppendorf 
Stainless steel beads (5 mm)                        Qiagen 
Syringes (1 ml, 30 ml) BD Plastipak 
Tissue culture plate (6 and 96 well) Falcon 
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2.1.4 Buffers and Solutions 
 
2.1.4.1 Gel electrophoresis  
50x TAE buffer  232 g Tris 
 57.1 ml conc. acetic acid 
 100 ml 0.5 M EDTA, pH 8.6 
 ad 1 l deionized water 
1x TAE buffer 
 
 100 ml 50x TAE buffer 
 ad 5 l deionized water 
Denaturing agarose gel sample  
loading buffer 
75 μl deionized formamide 
75 μl 10x MOPS buffer 
 120 μl 37% formaldehyde 
 90 μl sterile deionized water 
 50 μl glycerin 
 a spatula’s tip bromophenoblue 
 
2.1.4.2 Bacteria media 
LB agar 35 g LB-Agar (Sigma) 
ad 1 l MilliQ water 
 
LB medium 20 g LB-Broth (Sigma) 
ad 1l MilliQ water 
2.1.4.3 Zebrafish maintenance and work 
E3 („eggwater“)  3 g Red Sea Salt 
ad 10 l MilliQ water 
 
0.1 M KCl 0.745 g KCl 
ad 100 ml MilliQ water 
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1-phenyl-2-thiourea (PTU, 10x stock)  
 
304 mg PTU 
ad 1 l MilliQ water 
 
Lysis buffer  133 µl of 1.5 M Tris/HCl, pH8 
40 µl 0.5 M EDTA  
60 µl Tween 
60 µl Glycerol 
ad 20 ml MilliQ water 
 
Tricaine (3-amino benzoic 
acidethylester) 
 
400 mg Tricaine powder 
97.9 ml MilliQ water 
~2.1 ml 1 M Tris (pH 9) adjust to pH ~7 
100 ml total volume 
 
Tris/HCl, pH 7.8 181.17 g Tris 
Adjust pH to 7.8 with HCl 
Ad 1 l MilliQ water 
4% PFA 4 g PFA dissolved in 100 ml 1xPBS 
 
2.1.5 Kits and Reagents 
 
Product Company 
4-Hydroxynonenal (4-HNE) ELISA Kit Biovision 
4-Hydroxynonenal - CAS 75899-68-2 Sigma-Aldrich 
Gene Ruler DNA ladder mix (0.5 μg/μl) Thermo Fisher Scientific 
Glucose Assay Kit CBA086 Merck 
GoTaq® Green Master Mix  Promega 
Illustra PlasmidPrep Mini Spin Kit GE Healthcare Life Science 
Maxima First Strand cDNA Synthesis Kit 
with dsDNase 
molecular biology by thermo scientific 
MEGAshortscriptTM T7 invitrogen by Thermo Fisher Scientific 
miRNeasy Mini Kit QIAGEN 
mMESSAGE mMachineTM T7 invitrogen by Thermo Fisher Scientific 
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Power SYBR™ Green PCR Master Mix Kit Applied Biosystems 
Qiagen Plasmid Midi Kit QIAGEN 
QIAquick PCR Purification Kit QIAGEN 
RNeasy Mini Kit QIAGEN 
Tricaine (3-amino benzoic acidethylester) Sigma-Aldrich 
Trypsin/EDTA solution (25200-056) Gibco 
2.1.6 Plasmids 
 
pT7-gRNA  Addgene 
pT3TS-nCas9n Addgene 
 
2.1.7 Enzymes and buffers  
 
All restriction enzymes and buffers, including BamHI-HF, BglII, NEB Buffer 3, NEB 
CutSmart Buffer, SalI, SmaI, T4 DNA Ligase Buffer, T4 Ligase,T7 endonuclease, XbaI 
were purchased from New England Biolabs GmbH. 
Proteinase K was purchased from Roche 
 
2.1.8 Oligonucleotides 
 
CRISPR-construct name 
 
Oligonucleotide sequence (5‘ to 3‘) 
Aldh3a1-CRISPR#1-for TAGGGGTCTGGATCTGCCTGAC 
Aldh3a1-CRISPR#1-rev  AAACGTCAGGCAGATCCAGACC  
 
Genotyping primer name Primer sequence (5‘ to 3‘) 
Aldh3a1-CRISPR#1.7adjusted-for: ACATGGACTGAACAGTGACCTTGG 
Aldh3a1-CRISPR#1.10-rev: CTCACGCTCTGCCACCTTGAT 
Aldh3a1-rg-1.3adjusted-for: CTCTTTGTGAAATCCTAAACCCT 
Aldh3a1-rg-1.6-rev  TGTCTGCATGGCGTTCAGTGA 
 
qPCR primer name Primer sequence 
β-actin-qPCR-for ACGGTCAGGTCATCACCATC 
β-actin-qPCR-rev TGGATACCGCAAGATTCCAT 
b2m-qPCR-for ACTGCTGAAGAACGGACAGG 
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b2m-qPCR-rev GCAACGCTCTTTGTGAGGTG 
aldh1a2-qPCR-for AACCACTGAACACGGACCTC 
aldh1a2-qPCR-rev ATGAGCTCCAGCACACGTC 
aldh1a3-qPCR-for CGTGTTTGCAGACTCAGACC 
aldh1a3-qPCR-rev TGAAGAAAGCCCCCTTCTG 
aldh1l1-qPCR-for GCTGCCCAGACACAGAGG 
aldh1l1-qPCR-rev AACCCTCCCTTCTTATCACCA 
aldh1l2-qPCR-for AGCCGCTTCAATGGATGTAG 
aldh1l2-qPCR-rev GAACACCAGCGCATTTCTG 
aldh2.1-qPCR-for CGCACTGTATATCGCCAGTTTA 
aldh2.1-qPCR-rev GGACCAAACCCTGGGATAAT 
aldh2.2-qPCR-for TGCAGTCTCCTTCAGTGTGG 
aldh2.2-qPCR-rev TGCCCAGCCAGCATAATAC 
aldh3a1-qPCR-for CACTGTTGATACTTTACCTTTTGGAG 
aldh3a1-qPCR-rev CAAACGTGTGTTTCCCATGA 
aldh3a2a-qPCR-for TGATGAATCTGAGTGTTACATTGC 
aldh3a2a-qPCR-rev TGGCCCAAAGATCTCTTCC 
aldh3a2b-qPCR-for CACTTCTCTGTCAGCTCTCTGC 
aldh3a2b-qPCR-rev GATAGCGGCCCATACCACT 
aldh3b1-qPCR-for CATGACTCTTCCTGGTTTACCC 
aldh3b1-qPCR-rev TGATAGTTGCCCATCCCACT 
aldh4a1-qPCR-for TGGACCAAAGACATCCGATT 
aldh4a1-qPCR-rev AGCAGAACTTTGCAACTTGGT 
aldh5a1-qPCR-for GGGCCTCTTATCAACTCACG 
aldh5a1-qPCR-rev TCCATGATCCACAGCGTCT 
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aldh6a1-qPCR-for GTCTACGTGTCAATGCAGGTG 
aldh6a1-qPCR-rev TCTTTGGCCTGAGGTGAGAT 
aldh7a1-qPCR-for AACCGCAGCACCGAATATGT 
aldh7a1-qPCR-rev TCTGCTATGGTTGCCTGACG 
aldh8a1-qPCR-for CTCCAGCTTCTCCAATCAGG 
aldh8a1-qPCR-rev GTAAACGCTCCGCTCCAC 
aldh9a1a.1-qPCR-for GCTCTGTTCGAAATCTGTGTTCC 
aldh9a1a.1-qPCR-rev CGACCAGTTGCTGGCTCGTA 
aldh9a1a.2-qPCR-for TCCCATGGTGGCTAAAGTGT 
aldh9a1a.2-qPCR-rev TAGCTGCCATTTCCAAAACC 
aldh9a1b-qPCR-for GGAGCAAGCCAAGAACGA 
aldh9a1b-qPCR-rev GGATCTGCAGGGCTGAAA 
aldh16a1-qPCR-for CCACAGGGTGTTGTGACGGT 
aldh16a1-qPCR-rev 
 AGGAGGCCAGGAAGAGCAGT 
aldh18a1-qPCR-for GCACAGGAAGCCCTGTCTAT 
aldh18a1-qPCR-rev CTCTTCACGAGTGCTCACCA 
glo1-qPCR-for AGCAGACAATGCTGCGGGTG 
glo1-qPCR-rev CTACGGGAGAACGTCCAGGC 
ins-qPCR-for GGTCGTGTCCAGTGTAAGCA 
ins-qPCR-rev GGAAGGAAACCCAGAAGGGG 
insb-qPCR-for CCTGGAGACCTTGCTGGCTTTG 
insb-qPCR-rev CCAGGTGGTAGATGGTGCAGG 
isl1-qPCR-for AGGGTATGGCAGCCGAGGTC 
isl1-qPCR-rev GCTTGCATGCTTAGTACTTGGGC 
isl2a-qPCR-for CATCCCAGAACCTGTGCCAGT 
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isl2a-qPCR-rev ACTCGTATGACCCGTGGGCT 
isl2b-qPCR-for GCTGGGAGCGGGATACAAGG 
isl2b-qPCR-rev TCCGGACTTCTTTTTGGAATGATCC 
pdx1-qPCR-for ACACGCACGCATGGAAAGGACA 
pdx1-qPCR-rev GCGGGCGCGAGATGTATTTGTT 
 
2.1.9 Morpholinos 
 
All morpholinos were purchased from GENE TOOLS, LLC.  
 
SB-aldh3a1-MO#1 5’-GCCGCATTTCCTAATCAACAAGAGG-3’ 
(targets intron3 – exon4 junction) 
SB-aldh3a1-MO#2 5’-AACAAATCTATGCACCTTATCCAGA-3’ 
(targets exon4 – intron4 junction) 
SB-pdx1-Mo 5’-GATAGTAATGCTCTTCCCGATTCAT-3’ 
(targets translation start site) 
Control-MO 5’-CCTCTTACCTCAGTTACAATTTATA-3’ 
 
Genotyping primer name Primer sequence (5‘ to 3‘) 
Aldh3a1-mo-1.5-for AGGTGGCAGAGCGTGAGATG 
Aldh3a1-mo-1.4-rev  GAACCCCTCCTGTCACCACC 
 
  
2.1.10 Bacteria strain 
 
E.coli stbl3 competent cells    invitrogen by Thermo Fisher Scientific 
 
 
2.1.11 Zebrafish transgenic lines 
 
Three transgenic zebrafish lines were used: Tg(fli1:EGFP)93, Tg(hb9:GFP)(also called 
as Tg(mnx1:GFP) )94 and Tg(ins:nfsB-mCherry)50 for all the study of zebrafish (Danio 
rerio) experiments. 
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 Methods 
2.2.1 Animal studies 
2.2.1.1 Ethics 
All experimental procedures on animals were approved by the local government 
authority, Regierungspräsidium Karlsruhe and by Medical Faculty Mannheim (license 
no: G-98/15, G-160/14 and I-19/02) and carried out in accordance with the approved 
guidelines. 
2.2.1.2 Zebrafish maintenance 
Zebrafish lines were raised and staged as described95 under standard husbandry 
environment. Embryos/larvae were kept in E3 media at 28.5 °C with/without PTU (2.5 
ml in 25 ml) to suppress pigmentation. Adult zebrafish were kept under 13 h light/11 h 
dark cycle and fed with living shrimps in the morning and fish flake food in the 
afternoon. 
2.2.1.3 Morpholino and CRISPR/Cas9-mRNA injection 
Morpholino stock (8 or 16 µg/µl) were incubated at 65 °C for 5 minutes and diluted to 
4 or 6 µg/µl with 0.1 M KCl for using. CRISPRguide-RNA and Cas9 mRNA were each 
diluted to 200 ng/µl in 0.1 M KCl and mixed. Freshly layed zebrafish eggs were 
collected and arranged in a 1% agarose ramp with E3 media. One nanoliter of 
morpholino or CRISPRguideRNA-Cas9mRNA-mix was injected into the yolk sack or 
the cell of one-cell staged embryos, respectively. 3-4 h later, the eggs were sorted and 
undamaged fertilized eggs were kept in the Petri dish.  
2.2.1.4 Incubation of zebrafish embryos/larvae 
Fertilized zebrafish embryos were transferred into 6-well plate, around 30 embryos per 
well with 5 ml eggwater containing 0,003% PTU and 5 μM or 10 μM 4-HNE starting at 
3-4 hours post fertilization(hpf). Media were changed daily. At 24 hpf the chorion of 
zebrafish embryos was removed using sharp forceps. 
2.2.1.5 Microscopy and analysis of pancreatic and vascular alternations in larvae.  
Tg(hb9:GFP) embryos and Tg(fli1:EGFP) larvae were anesthetized with 0.003% 
tricaine in egg water and Tg(hb9:GFP) were embedded in 1% low-melting-point 
agarose dissolved in egg water for visualisation on an inverted microscope (Leica DMI 
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6000 B) with a camera (Leica DFC420 C) and the Leica LAS application suite 3.8 
software. The endocrine islet was imaged at 10x and quantified using ImageJ.  
For in vivo analysis of  pancreatic  structure,  Tg(hb9:GFP) and Tg(ins:nfsB-mCherry) 
larvae were anesthetized in 0.0003% tricaine at 72 hpf. Images were taken with an 
inverted microscope (Leica DMI 6000 B) with a camera (Leica DFC420 C) and the 
Leica LAS application suite 3.8 and 4.13.  The endocrine pancreatic area and β cell 
mass were imaged at 20x and 8x, respectively. Quantification were done by using 
ImageJ. 
For in vivo imaging of the zebrafish trunk vasculature, Tg(fli1:EGFP) larvae were 
anesthetized in 0.0003% tricaine at 96 hpf, lying on the side. Images were taken via a 
DM6000 B microscope with Leica TCS SP5 DS scanner with 600 Hz, 1024x512 pixels 
and 1 μm thick z-stacks. For quantification of altered trunk vessels, the first 5 
intersegment vessel (ISV) and dorsal longitudinal anastomotic vessel (DLAV) pairs of 
each zebrafish larvae were skipped and in the following 17 pairs alterations were 
counted. The development of new blood vessels referred to ‘hyper branches’, and 
altered intersegment vessels that either miss connections to others or show slight 
malformations(thin, thick or wrong direction) were grouped as ‘abnormal ISVs’ and 
counted. 
For in vivo imaging of the zebrafish retinal hyaloid vasculature, Tg(fli1:EGFP) larvae 
were anesthetized in 0.0003% tricaine at 120 hpf, and fixed in 4% PFA/PBS overnight 
at 4°C afterwards. Fixed larvae were washed three times for 20 minutes in double 
distilled water (ddH2O) and incubated for 90 min at 37°C in 0.5% Trypsin/EDTA 
solution (25200-056, Gibco) buffered with 0.1 M TRIS (Nr. 4855.3, Roth) dilution and 
adjusted to pH 7.8 with 1 M HCl solution. Larval hyaloid vasculature was dissected 
under a stereoscope and displayed in PBS for visualisation according to Jung’s 
protocol96. Confocal images for phenotype evaluation were acquired using a confocal 
microscope (DM6000 B) with a scanner (Leica TCS SP5 DS) utilising a 20x0.7 
objective, 1024 × 256 pixels, 0.5 µm Z-steps. Vascular diameters were measured at 
two different positions by ImageJ and new blood vessels by neoangiogenesis were 
counted and addressed as “sprouts” within the circumference of the hyaloid per 
sample. 
2.2.1.6 Overfeeding of adult zebrafish 
Adult zebrafish were set in groups based on genotype and feeding method. And the 
feeding protocol was adapted from Oka97. For normal feeding: each fish received a 
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normal amount of artemia (twice per day and 5 mg dry weight artemia in total). For 
overfeeding: each fish was overfed by receiving a exceed amount of artemia (three 
times per day and 60 mg dry weight artemia in total). Animals were sacrificed for 
experiments after eight weeks feeding.  
2.2.1.7 Dissection of adult zebrafish 
Adult zebrafish were transferred into single boxes and fasted overnight. 16 hours later, 
fish were with 0.5 g flake food for 1 hours followed by 1 hours postprandial 
experiments. Afterwards, fish were euthanized with 0.025% tricaine until the operculum 
movement stopped entirely. Then blood was collected from the caudal vein and blood 
glucose was measured by a glucometer. Next, fish were sacrificed by beheaded 
treatment and transferred into operation stage covered with ice-cold PBS. Livers were 
isolated, weighed, snap frozen in liquid nitrogen and stored at -80 °C for metabolomics 
analysis. The whole fish head was transferred into 4% PFA/PBS for 24 h at 4 °C for 
further retinal analysis. 
2.2.1.8 Microdissection and visualisation of retinal vasculature 
Retina dissection was prepared according to Wiggenhauser’s protocol98. In brief, PFA-
fixed heads from adult zebrafish were transferred into PBS and eyes were removed 
from the head.  Retina was isolated from eye and washed twice with 1xPBS for 5 min. 
Washed retina was mounted in mounting media and covered with a cover slide. 
Images were made by using DM6000 B confocal microscope with Leica TCS SP5 DS 
scanner. Parameter: 600 Hz, 1024x1024 pixels and 1.5 μm thick of z-stacks were. 
Quantification of branch points and sprouts was performed by using GIMP and ImageJ 
in squares of 350*350 μm2.  
 
2.2.2 Molecular biology 
 
2.2.2.1 Design of CRIRPR-oligonucleotides 
Aldh3a1 CRISPR target site was identified and selected using the ZiFiT Targeter 4.1 
(http://zifit.partners.org/ZiFiT/ChoiceMenu.aspx). Oligonucleotides were synthesized 
by Sigma-Aldrich.  
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2.2.2.2 Annealing of CRISPR oligonucleotides 
Oligonucleotides were dissolved in autoclaved MilliQ water and adjust the 
concentration to 100 µM. 
 
1x Mix for annealing:  
 
2 µl forward oligonucleotide (Aldh3a1-CRISP#1-for) 
2 µl reverse oligonucleotide (Aldh3a1-CRISP#1-rev) 
2 µl NEB Buffer 3  
14 µl  autoclaved MilliQ water 
 
 
Annealing: 
 
95 °C   5 min  
0.1 °C/sec  cooling down  
50 °C   10 min 
1 °C/sec cooling down  
4 °C   (∞)  
2.2.2.3 Restriction and ligation of gRNA-plasmids 
1x Mix for annealing:  
 
1 µl   annealed oligonucleotide solution (from last section) 
400 ng  pT7-gRNA (adjust concentration) 
1 µl    NEB Buffer 3  
1 µl    T4 DNA Ligase Buffer 
0.5 µl    BsmBI 
0.3 µl   BglII 
0.3 µl    SalI 
0.5 µl    T4 Ligase   
 
ad 10    µl sterile MilliQ water 
Restriction: 
 
37 °C for 60 min and 16 °C for 45 min, three cycles 
37 °C for 30 min 
55 °C for 30 min 
80 °C for 15 min 
4 °C,  (∞) 
 
Complete ligation mix can be used for the following transformation.  
 
2.2.2.4 Transformation of E. coli  
 
Competent E. coli  Stbl3 stock was thawed on ice. 50 µl of E. coli were added to the 
ligation mixture (see in last section) and slightly stirred. The mixture was then chilled 
on ice for 20 min. Afterwards the tube was put in a water bath at 42 °C for exactly 90 
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sec. Then immediately put it back on ice for at least 90 sec. One ml LB medium was 
added and the tube was incubated in a bacterial shaker for 45 min (37 °C and 220 
rpm). Subsequently, the tube was centrifuged for 5 min (4 °C and 6000 rpm). Discarded 
900 µl supernatant and kept the rest to resolve the pellet carefully by avoiding air 
bubbles. Under hygienic conditions (the flame of a gas burner) the remaining mixture 
was pipetted on a LB-Amp plate and plated uniformly with a freshly flamed glass 
pipette. The plate was put overnight in an incubator at 37 °C. 
2.2.2.5 Plasmid isolation and sequencing 
Single colony was picked from cultured LB-agar plates and inoculated in a 3 ml culture 
of LB medium with ampicillin.  Incubated the whole culture overnight at 37 °C and 220 
rpm. Then the Illustra Plasmid Prep Mini Spin Kit was used for plasmids isolation 
according to the manufacturer’s protocol. 
For plasmid midi preparations, single colony was picked and inoculated in a 3 ml 
culture of LB medium with ampicillin. Incubated the whole culture at 37 °C and 220 
rpm for 7 h. Plasmid Midi Kit (Qiagen) was used for plasmids isolation according to the 
manufacturer’s protocol. 
Purified plasmid was diluted to the following concentration: 75 ng in a volume of 15 µl. 
Sanger sequencing was performed by Eurofins Genomics.  
2.2.2.6 CRISPR-guideRNA and Cas9-mRNA in vitro transcription 
SmaI and XbaI cutting enzymes were used for linearization of pT7-gRNA and pT3Ts-
nCas9mRNA, respectively. Then linearized plasmids were purified with the PCR 
purification kit (Qiagen). In vitro RNA transcription was performed using T7 
MEGAshortscript kit (Invitrogen) for guideRNAs and mMESSAGE MACHINE Kit 
(Invitrogen) for Cas9-mRNA.Purification of RNA was done via the miRNeasy Mini 
(Qiagen) or RNeasy Mini (Qiagen) kit. RNA concentration was determined and RNA 
samples were made foe aliquots and stored at -80 °C, until used for injection. 
2.2.2.7 Isolation of genomic DNA  
Whole zebrafish larvae or cut fins of adult zebrafish were transferred into 0.2 ml PCR 
tubes and 20 μl lysis buffer was added. After incubation at 98 °C for 10 min, 10 μl 
proteinase K was added following incubation at 55 °C for at least 4h. Then flicked the 
tubes and incubated at 55 °C for another hour. Heated up to 98 °C for 10 min and 
genomic DNA was stored at -20 °C. 
Materials and methods 
 28 
2.2.2.8 Polymerase chain reaction (PCR) and PCR purification 
Polymerase chain reaction (PCR) was performed by using 12.5 μl GreenTaq-mix, 2 μl 
forward primer, 2 μl reverse primer, 6.5 μl sterile MilliQ water and 2 μl DNA template. 
The following program was used: 
 
Beginning denaturation 95 °C, 3 min 
Denaturation 95 °C, 30 s 
Annealing Specific temperature according to the primer, 30 s 
Elongation 72 °C, specific elongation time according to the PCR product 
size 
From denaturation to elongation, 34-cycle repetition were performed. 
Final elongation 72 °C, 10 min 
 
For genotyping, the QIAquick PCR Purification Kit was used and genotyping PCRs 
were purified according to the manufacturer’s protocol.  
 
2.2.2.9 DNA gel electrophoresis 
An agarose gel (1-3% agarose in TAE buffer) was performed for the DNA fragments 
separation. Using peqlab electrophoresis chambers, the gel was run at 120 V (100 ml 
gel) in TAE up to 2h. 
 
2.2.2.10 RNA isolation from larvae and adult zebrafish organs. 
Larvae from different developmental time point were anesthetized with 0.003% tricaine 
and the yolk sac was removed by pipetting embryos up and down and centrifuging for 
5 min at 14000 rpm. The supernatant was discarded and the sediment was used for 
the following experiment. Adult zebrafish organs were collected during fish dissection 
and homogenised samples by tissuelyser were used for the following experiment. 
Lysis and purification of the larvae/adult zebrafish organs were performed with the 
RNeasy Mini Kit (Qiagen) according to the manufacturer’s protocol chapter 
“Purification of Total RNA from Animal Tissue”. RNA concentration was measured with 
a photometer and checked on an 1% agarose gel for integrity. Then samples were 
made for aliquots and stored at -80 °C until use.  
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2.2.2.11 cDNA synthesis from RNA (RT-PCR) 
The Maxima First Strand cDNA Synthesis Kit was used for reverse transcription PCR 
(RT-PCR) for generation of cDNA according to the manufacturer’s protocol. One µg 
RNA were utilised for template. The cDNA was made for aliquots and stored at -20 °C 
until use.   
2.2.2.12 Real time quantitative PCR (RT-qPCR) 
Primer (see in 2.1.8) were designed with the Primer-BLAST tool from NCBI using the 
transcript. All samples were used with Power SYBR™ Green PCR Master Mix Kit in 
96-well reaction plates. The qPCR reaction was performed with QuantStudio 3 Real-
Time-PCR-System.  
  
A Primer-Mix was prepared for each gene: 2 µl of both forward and reverse primers 
Stock (100 µM) were mixed with 96 µl autoclaved MilliQ water. 
 
Each well: 1 µl Primer Mix 
   5 µl  Power SYBR™ Green PCR Master Mix 
   4µl  cDNA-autoclaved MilliQ water-Mix  
(containing 20 ng cDNA) 
   Total  10 µl 
 
2.2.2.13 RNA-Seq Analysis. 
RNA were isolated from aldh3a1+/+ and aldh3a1-/- larvae at 48hpf. Library construction, 
and sequencing were performed with BGISEQ-500 (Beijing Genomic Institution, 
www.bgi.com, BGI). Gene expression analysis were conducted by the Core-Lab for 
microarray analysis, Centre for medical research (ZMF). In brief, main procedure was 
done with R and bioconductor using the NGS analysis plackage systempipeR 99. 
Quality control of raw sequencing reads was performed using FastQC (Babraham 
Bioinformatics). Low-quality reads were removed using trim_galore (version 0.6.4). 
The resulting reads were aligned to zebrafish genome version danRer11 from UCSC 
and counted using kallisto version 0.46.1 100. The count data was transformed to log2-
counts per million (logCPM) using the voom-function from the limma package101. 
Differential expression analysis was performed using the limma package in R.  A false 
positive rate of α= 0.05 with FDR correction was taken as the level of significance. 
Volcano plots and heatmaps were created using ggplot2 package (version 2.2.1) and 
the complexHeatmap  (version 2.0.0)102.  
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2.2.3 Biochemical analysis 
 
2.2.3.1 Protein sequence alignment 
The amino acid sequences of the aldh3a1 proteins from zebrafish 
(X1WBM4_DANRE), human (AL3A1_HUMAN) and mouse (AL3A1_MOUSE) were 
accessed from the UniProt Database (http://www.uniprot.org/). For the comparison, 
the genes were selected and aligned with the UniProt-own alignment tool 
(http://www.uniprot.org/align/). 
2.2.3.2 Enzyme activity assay 
Enzyme activity assay was performed by the laboratory of Prof. Dr. P. Nawroth 
(Department of Medicine I and Clinical Chemistry, Heidelberg University, Germany)  
96 hpf old larvae were collected for the measurement. ALDH activity was assayed at 
25 °C in 75 mM Tris-HCl (pH 9.5) containing 10 mM DL-2-amino-1propanol, 0.5 mM 
NADP and 2 mM MG/4 mM 4-HNE/ 5Mm Acetaldehyde by measuring the rate of NADP 
formation at 340 nm103. Glo1-activity was determined spectrophotometrically 
monitoring the change in absorbance at 235 nm caused by the formation of S-D-
lactoylglutathione104. 
 
2.2.3.3 Determination of methylglyoxal 
The determination of MG was performed by stable isotopic dilution analysis via LC-
MS/MS105 by the laboratory of Prof. Dr. P. Nawroth (Department of Medicine I and 
Clinical Chemistry, Heidelberg University, Germany)   
In brief, frozen Zebrafish larvae were treated with precipitation solution (Trichloracetic 
acid 20% w/v in 0.9% NaCl), incubated with an internal standard and derivatized with 
1,2-Diaminobenzene. Quantification was carried out using a XEVO TQ-S tandem 
quadrupole mass spectrometer. 
2.2.3.4 Metabolomic analysis 
Detection was done in cooperation with the Metabolomics Core Technology Platform 
from the Centre of Organismal Studies Heidelberg by Gernot Poschet and Elena 
Heidenreich.  
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Zebrafish larvae at 96 hpf age were anesthetized with 0.003% tricaine. Adult zebrafish 
organs were collected during fish dissection. The detection was performed either by 
ultra-performance liquid chromatography with fluorescence detection (UPLC-FLR)106 
or semi-targeted gas chromatography-mass spectrometry (GC/MS) 107 analysis.  
2.2.3.5 Whole-body glucose determination in zebrafish larvae.  
Zebrafish larvae from different developmental time point were collected and snap 
frozen. Approximately 20-25 larvae per clutch were homogenized in glucose assay 
buffer with by the ultrasonic homogenizer sonicator, 90% intensity, and 15seconds for 
2 times.  Glucose content was determined according to manufacturer’s instruction 
(Glucose Assay Kit, CBA086, Sigma-Aldrich). 
 
2.2.3.6 4-HNE determination in zebrafish larvae 
Zebrafish larvae from 96hpf were collected and snap frozen. Approximately 40-50 
larvae per clutch were homogenized in PBS with by the ultrasonic homogenizer 
sonicator, 90% intensity, 15 seconds for 2 times.  4-HNE amount was determined 
according to manufacturer’s instruction (4-Hydroxynonenal ELISA Kit, E4645, 
Biovision). 
 
2.2.4 Software 
 
Agarose gel imagines was carried out with IntasGelCaptureEntry (INTAS). For the 
quantification of trunk vasculature, endocrine pancreatic area and β cell mass, the 
Leica LAS V3.8 and V4.13 software was used. Analysis of retinal vasculature was 
carried out by using LAS AF Lite Software from Leica for taking screen shots, Gimp for 
image cutting and ImageJ for quantification. The “GCMS solution” software 
(Shimadzu®) was used for data processing of the GC/MS analysis. Statistics were 
calculated with GraphPad Prism 6.01 and 8.3.0. 
 
2.2.5 Statistical analysis 
 
Results are expressed as mean with standard deviation (mean ± SD). Statistical 
significance between different groups was analysed using Student’s t-test, Mann-
Whitney-U-test, one-way ANOVA (followed either by post hoc Bonferroni’s, Sidak’s 
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multiple comparison) in GraphPad Prism 6.01 or 8.3.0. p-values of 0.05 were 
considered as significant: *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
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3 RESULTS 
 Sequence alignment of Aldh3a1 across different species and analysis of the 
aldh3a1 mRNA expression in larvae and adult organs of zebrafish.  
 
ALDH3A1 (Aldh3a1) enzyme system exists in human, mouse and zebrafish 108, 109. At 
first, the amino acid sequence alignment was blasted among these three species to 
compare ALDH3A1 (Aldh3a1) proteins among these three species. The alignment 
showed zebrafish Aldh3a1 shares 61.6% similarity of protein with human ALDH3A1 
and 57.6% with mouse; as an enzyme encoding gene, the active site is the same in 
these three species (Fig.1A).   
Then RT-qPCR was performed to investigate the potential expression differences of 
aldh3a1 mRNA level in different time points of larvae and adult organs of zebrafish. 
Results showed an increased trend of aldh3a1 mRNA as the larva develops by around 
3-fold elevation at 96 hpf than 24 hpf. While brain and eye are the most expressed 
adult organs, which were 11- and 7-fold significant increase compared to heart 
(reference organ) (Fig.1B). 
 
Altogether, this part identifies aldh3a1 mRNA exists in zebrafish larvae and different 
adult organs and the possibility for studying ALDH3A1 (Aldh3a1) enzyme system by 
using zebrafish model.  
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Fig.1 Sequence alignment of Aldh3a1 across different species and the expression of aldh3a1 
mRNA in larvae and adult organs of zebrafish.  
 
(A). Amino acid alignment showed a high similarity between the different species of the active site(red 
frame) and peptidase dimerization domain (yellow); first line: zebrafish Aldh3a1 dipeptides; second line: 
human ALDH3A1; third line: mouse Aldh3a1. (B). Heatmap of  aldh3a1 mRNA expression in wildtype 
zebrafish showed an increased trend from 24hpf to 96hpf in larvae and expressed mostly in brain and 
eye in adult organs, which is significantly incremental than heart(reference organ). Higher and lower 
expression is displayed in pink and blue, respectively.  Expression of genes was determined by RT-
qPCR and normalized to b2m. Larvae stage: n = 3 clutches with 30 larvae, adult organs: n=4 with one 
organ per sample. For statistical analysis one-way ANOVA followed by Sidak‘s multiple comparison test 
was applied, *p<0.05, **p<0.01. RT-qPCR, real-time quantitative polymerase chain reaction; hpf, hours 
post fertilization; b2m, β2 microglobulin. 
 
 Generation and validation of Aldh3a1 knock out in zebrafish. 
 
Since aldh3a1 knockout zebrafish model do not exist thus far and in order to explore 
the function of Aldh3a1 in zebrafish, aldh3a1-/- zebrafish were generated by 
CRISPR/CAS9 technology 110. I designed a CRISPR-guideRNA (gRNA) targeting exon 
Results 
 35 
2 of aldh3a1 and then identified 11 bases insertion in knockout animal models (Fig.2A), 
which leads to the formation of a Stop-codon afterwards (Fig.2B).  
 
Fig.2 Generation of Aldh3a1 knockout zebrafish by using CRISPR-Cas9 technology. 
(A). Aldh3a1-CRISPR-target site was designed in exon 2 of aldh3a1 and CRISPR/Cas9-induced 
insertions of 11 nucleotides was selected for further aldh3a1 mutant line generation and maintenance. 
Genotype was analyzed using sequencing chromatograms of PCR-amplified aldh3a1 region, containing 
the aldh3a1 target site. Chromatogram shows aldh3a1 wild type, heterozygous, and homozygous 
sequencing results. (B).Amino acid sequence shows a stop-codon in exon2 of aldh3a1–/–. (C). 
Microscopic images showed normal gross morphology of aldh3a1-/- larvae in comparison with aldh3a1+/+ 
larvae at 96 hpf. Black scale bar: 500 μm. (D). Adult fish number among different genotypes was in line 
with the Mendelian Inheritance in the first generation of F2:   aldh3a1+/+ =14, aldh3a1+/- =27, aldh3a1-/- 
=12. (E). Aldh3a1-/- zebrafish showed decreased enzyme activity (acetaldehyde and 4-HNE as 
substrate) measured by spectrophotometric analysis in zebrafish lysates at 96 hpf; n = 6 clutches with 
46 to 50 larvae. Mean± SD, for statistical analysis Student’s t-test was applied, *p<0.05, **p<0.01. PAM, 
protospacer-adjacent motif; WT, wild type.  
Enzyme-activity assays were performed by Jakob Morgenstern/Tomas Fleming. 
 
The gross morphology showed no difference between homozygous and wild type 
zebrafish larvae at 96hpf (Fig.2C). Meanwhile the fish number was counted by 
genotype during the first generation of F2, the number of wild type, heterogynous and 
homogenous adult fish at four months old were 14, 27 and 12 respectively , which was 
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in line with the Mendelian Inheritance111(Fig.2D) indicating no survival adversity in 
aldh3a1-/- mutants.  To evaluate whether the 11 bases insertion in aldh3a1 mutants 
causes the non-functional Aldh3a1 protein after translation, ALDH activity was 
measured by using its different substrates. Aldh3a1 mutants showed around 30% 
significant decrease of ALDH activity by both acetaldehyde and 4-HNE substrates 
(Fig.2E). All the above have proved the successful generation of aldh3a1 knockout 
mutants. 
 
 Vasculature alternations in aldh3a1 mutants are enhanced by pdx1 morpholino 
injection. 
 
To study vascular developmental effects potentially caused by Aldh3a1 knock out, I 
investigated the trunk vasculature development in aldh3a1 mutants at first. 
Tg(fli1:EGFP) zebrafish reporter line, in which endothelial cells express enhanced 
green fluorescence protein(EGFP) and enables to analyse the vasculature under 
microscope93, was used to perform this experiment. Results showed no difference in 
hyper branches but a slightly increase in ISVs (including missing, wrong direction, thin, 
thick intersegment vessels) between aldh3a1+/+ and aldh3a1-/- zebrafish larvae at 
96hpf (Fig.3). As Pdx1 is a transcription factor and necessary for pancreatic 
development including β cell  maturation and duodenal differentiation112, transient 
knock down can cause hyperglycaemia and mimic diabetic condition. According to this 
strategy, pdx1 morpholino was used to inject the embryos at one-cell stage to see if it 
could enhance the phenotype. Aldh3a1-/- larvae showed enhanced vasculature 
alternations in both increased hyper branches and abnormal ISV numbers compared 
to aldh3a1+/+ larvae at 96hpf after pdx1 morpholino injection (Fig.4). 
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Fig.3 Trunk vasculature alterations between aldh3a1-/- and aldh3a1+/+ Tg(fli1:EGFP) zebrafish 
larvae. 
Loss of Aldh3a1 enzyme activity partially altered vasculature morphology, leads to increased formation 
of abnormal ISV in trunk vasculature of Tg(fli1:EGFP) zebrafish larvae at 96hpf. (A). Light microscopic 
images showed the gross morphology of zebrafish larvae and black boxes indicate region seen in the 
confocal images. White arrows indicate the abnormal ISV, including missing, wrong direction, thin, thick 
intersegment vessels. White scale bar = 100 μm, black scale bar =500 μm. (B-C). Quantification of 
abnormal ISV and hyperbranches formation; n = 39 larvae (aldh3a1+/+) and n = 34 larvae (aldh3a1-/-). 
Mean± SD, for statistical analysis Student’s t-test was applied *p<0.05. ISV, intersegmental vessels. 
NS, not significant.  
 
 
Since retina conducts one of the most metabolically active tissues in the body113, 
zebrafish retinal hyaloid vasculature is considered as an appropriate model to analyse 
genetics and disease114. To study the short-term influence of aldh3a1 knock out and 
hyperglycaemia on the retinal microvasculature, I analysed the retinal hyaloid network 
in Tg(fli1: EGFP)  zebrafish larvae at 120 hpf regarding the genotype and diabetic 
condition. Aldh3a1-/- larvae showed widen inner optic circle (IOC) branch diameters 
but no change in sprouts. After the pdx1 morpholino injection, IOC branch diameters 
and the number of sprouts increased aggregately in aldh3a1-/- compared to aldh3a1+/+ 
larvae (Fig.5). 
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Fig.4 Trunk vasculature alterations are enhanced by endogenous pdx1 expression silencing in 
aldh3a1-/- Tg(fli1:EGFP) zebrafish larvae. 
Endogenous pdx1 expression silencing by pdx1 morpholino injection leads to enhanced formation of 
abnormal ISV and hyperbranches in trunk vasculature of aldh3a1-/- Tg(fli1:EGFP) zebrafish larvae at 
96hpf. (A).Light microscopic images showed the gross morphology of zebrafish larvae and black boxes 
indicate region seen in the confocal images. White arrows indicate the abnormal ISV and white deltas 
indicate the hyperbranches. White scale bar = 100 μm, black scale bar =500 μm.  (B-C). Quantification 
of abnormal ISV and hyper branches formation; n = 15-17 per group. 6 ng of morpholinos: Control-MO 
and SB-pdx1-MO were injected into the one-cell stage of zebrafish embryos respectively. Mean± SD, 
for statistical analysis one-way ANOVA followed by Sidak‘s multiple comparison test was applied, 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.ISV, intersegmental vessel; MO, morpholino; NS, not 
significant. 
 
To sum, these data indicate knock out of aldh3a1 can lead to trunk and hyaloid 
vasculature alternations and be enhanced under diabetic condition in zebrafish larvae. 
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Fig.5 Retina hyaloid vasculature alterations are enhanced by endogenous pdx1 expression 
silencing in aldh3a1-/- Tg(fli1:EGFP) zebrafish larvae. 
Endogenous pdx1 expression silencing by pdx1 morpholino injection leads to widen IOC branch 
diameters and increased sprouts formation in hyaloid vasculature of aldh3a1-/- Tg(fli1:EGFP) zebrafish 
larvae at 120 hpf. (A). Representative confocal images of hyaloid vasculature after Control-MO or SB-
pdx1-MO injection.  White scale bar = 20 µm. (B-C). Quantification of the IOC branch diameter and 
sprouts formation, n=8-12 per group. 6 ng of morpholinos: Control-MO and SB-pdx1-MO were injected 
into the one-cell stage of zebrafish embryos respectively. Mean± SD, for statistical analysis one-way 
ANOVA followed by Sidak‘s multiple comparison test was applied, *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001. MO, morpholino; IOC, inner optic circle. NS, not significant. 
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 Early pancreas is impaired by aldh3a1 morpholino injection. 
 
As aldh3a1 mutants in zebrafish pancreas transgenic reporter line haven’t be 
generated yet, for Aldh3a1 functional investigation during pancreas development and 
its interaction with Pdx1, an Aldh3a1 knockdown strategy is essential. Two 
morpholinos, SB-aldh3a1-MO#1 and SB-aldh3a1-MO#2, were designed to reduce 
aldh3a1 expression in zebrafish transiently by the antisense approach. Two 
morpholinos target intron3-exon4 and exon4-intron4 junction of aldh3a1-201 
respectively (Fig.6A). Six nanograms of morpholinos were injected into the one-cell 
stage of zebrafish embryos. The efficiency of morpholino was validated by RT-PCR 
gel, which showed decreased wild type aldh3a1 but expression of morphant aldh3a1 
in the gel upon SB-aldh3a1-MO#1 and SB-aldh3a1-MO#2 injection (Fig.6B). On the 
other side, microscopic images showed normal gross morphology of SB-aldh3a1-
MO#1 and SB-aldh3a1-MO#2 injected larvae at 48 hpf in comparison with Control-MO 
injected larvae indicating that the aldh3a1 morpholinos don’t cause other off-target or 
toxic effects in extra (Fig.6C). 
 
Fig.6 Aldh3a1 morpholino design and validation. 
(A). SB-aldh3a1-MO#1 and SB-aldh3a1-MO#2 target intron3-exon4 and exon4-intron4 junctions of 
aldh3a1-201 respectively. (B). Validation of splice-blocking morpholinos: SB-aldh3a1-MO#1 and SB-
aldh3a1-MO#2. RT-PCR of ControlMO, SB-aldh3a1-MO#1 and SB-aldh3a1-MO#2 injected larvae 
showed wild type and generation of morphant aldh3a1 signals at 48 hpf. 6 ng of morpholinos: Control-
MO, SB-aldh3a1-MO#1 and SB-aldh3a1-MO#2 were injected into the one-cell stage of zebrafish 
embryos respectively. (C) Microscopic images showed normal gross morphology of zebrafish larvae at 
48 hpf after morpholino injection. Black scale bar =500 μm. WT, wild type; MO, morpholino; Morph: 
morpant. 
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Subsequently I wanted to investigate if Aldh3a1 plays an important role in the 
development of pancreas. First, the primary pancreas islet size was analysed by using 
Tg(hb9:GFP) transgenic reporter line(also known as Tg[mnx1:GFP]), as hb9 is 
involved in spinal cord motor neuron cell fate specification and type B pancreatic cell 
differentiation115. The area size of primary endocrine islet showed decreased 
dimensions with aldh3a1 morpholino injection in zebrafish larvae at 72hpf (Fig.7). Then  
β cell  mass analyses was carried out  by using Tg(ins:nfsB-mCherry) transgenic 
reporter line, which provides not only an suitable model for β cell regeneration, but also 
an alternative strategy to manipulate cell interactions during early pancreas 
upgrowth50.  After the quantification, the early β cell mass size showed significantly 
decrease with SB-aldh3a1-MO#2 injection and a descendant trend with SB-aldh3a1-
MO#1 injection (Fig.8). 
 
 
Fig.7 Area size of the early primary endocrine islet in Tg(hb9:GFP) zebrafish larvae shows 
reduced dimensions by aldh3a1 morpholino injection.  
Aldh3a1 morpholino injection induces reduced dimensions of early primary endocrine islet in 
Tg(hb9:GFP) zebrafish larvae at 72hpf. (A). Representative fluorescence microscope pictures of the 
early developing endocrine pancreas in zebrafish larvae with morpholino injection. White box indicates 
the developing pancreas. White scale bar = 100 µm, grey scale bar = 50 µm. (B). Quantification of area 
size of the early primary endocrine islet, n=20-30 per group (SB-pdx1-MO injection as positive control, 
n=9). 6 ng of morpholinos: Control-MO, SB-aldh3a1-MO#1, SB-aldh3a1-MO#2 and SB-pdx1-MO were 
injected into the one-cell stage of zebrafish embryos respectively. Mean± SD, for statistical analysis 
one-way ANOVA followed by Sidak‘s multiple comparison test was applied, ***p<0.001, ****p<0.0001. 
 
Taken together, these results suggest knock down of Aldh3a1 can impair the primary 
pancreas development in zebrafish larvae.  
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Fig.8 Early β cell mass in Tg(ins:nfsB-mCherry) zebrafish larvae shows reduced trends by 
aldh3a1 morpholino injection.  
Aldh3a1 morpholino injection induces reduced trend of β cell mass in Tg(ins:nfsB-mCherry) zebrafish 
larvae at 72 hpf. (A). Representative fluorescence microscope pictures of the early β cell mass in 
zebrafish larvae with morpholino injection. White box indicates the β cell mass area. White scale bar = 
100 µm, grey scale bar = 50 µm. (B). Quantification of area sizes of the β cell mass area, n=16-33 per 
group. 6 ng of morpholinos: Control-MO, SB-aldh3a1-MO#1, SB-aldh3a1-MO#2 and SB-pdx1-MO were 
injected into the one-cell stage of zebrafish embryos respectively. Mean± SD, for statistical analysis 
one-way ANOVA followed by Sidak‘s multiple comparison test was applied, *p<0.05, ****p<0.0001. 
 
 Ins mRNA level is reduced and the whole-body glucose is elevated in both 
Aldh3a1 transient knockdown and permanent knockout zebrafish larvae. 
 
Pancreas plays a key role in insulin secretion and glucose homeostasis regulation 116. 
In order to clarify the consequence of pancreatic dysplasia caused by Aldh3a1 knock 
down while also validate the function role of Aldh3a1 in diabetes, insulin related gene 
mRNA expression and the whole-body glucose were determined.  I found, 
preproinsulin (ins) and pdx1 gene mRNA significantly reduced in both Aldh3a1 
knockdown and knockout larvae at 48hpf, while preproinsulin b (insb), another insulin-
encoding gene involved in glucose homeostasis regulation and also acting as a pro-
growth, survival, and neurotrophic factor during development117, is unaltered in 
aldh3a1-/- larvae and wild type zebrafish larvae with aldh3a1 morpholino injection 
(Fig.9 A-B). Besides, in aldh3a1-/- larvae, pancreas development related genes, ISL 
LIM homeobox 1 (isl1) and ISL LIM homeobox 2a (isl2a) mRNA showed decreased 
trends while ISL LIM homeobox 2b (isl2b)  mRNA reduced enormously and 
Results 
 43 
significantly compared to aldh3a1+/+ larvae, which exhibited similar expression level 
with aldh3a1+/+ larvae after pdx1 morpholino injection (Fig.9B).  
 
 
Fig.9 Both transient knock down and permanent knock out of Aldh3a1 leads to the reduced pdx1 
and insulin mRNA level. 
(A). ins, insb and pdx1 mRNA expression level in wild type larvae at 48hpf after Control-MO, SB-
aldh3a1-MO#1 and SB-aldh3a1-MO#2 injection. (B). ins, insb, pdx1 and pancreas related gene, isl1, 
isl2a and isl2b mRNA expression level among aldh3a1+/+, aldh3a1-/- larvae and SB-pdx1-MO injected 
aldh3a1+/+ larvae at 48hpf. 6 ng of morpholinos: ControlMO, SB-aldh3a1-MO#1, SB-aldh3a1-MO#2 and 
SB-pdx1-MO were injected into the one-cell stage of zebrafish embryos respectively. Expression of 
mRNA was analysed by RT-qPCR and expression was normalized to b2m. Values for Control-MO 
injected wild type larvae (A) and aldh3a1+/+ zebrafish larvae (B) were standardized to1, n = 3-4 clutches 
with 30 larvae per group. Mean± SD, for statistical analysis one-way ANOVA followed by Sidak‘s multiple 
comparison test was applied,*p<0.05, **p<0.01, ***p<0.001. b2m, β2 microglobulin; ins, preproinsulin; 
insb, preproinsulin b; isl1, ISL LIM homeobox 1; isl2a, ISL LIM homeobox 2a; isl2b, ISL LIM homeobox 
2b;NS, not significant. 
 
 
To further study how gene transcription alters and functions due to Aldh3a1 knock out, 
all expression patterns were analysed with full genome RNA-Seq between aldh3a1+/+ 
and aldh3a1-/- larvae at 48hpf. Principal component analysis (PCA) showed the 
components of each individual samples 118 and aldh3a1+/+ and aldh3a1-/- plots are 
totally separate in PC1 axis (Fig.10A). Volcano plot of statistically significant 
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differentially expressed genes at P 0.05 identified from the RNA-Seq libraries showed 
there were around 8 thousand gene down-regulated and 6.5 thousand gene up-
regulated in aldh3a1-/- zebrafish larvae (Fig.10 B).Then, for better understanding how 
the impaired pancreas reflects in the transcriptome level,  gene set enrichment analysis 
(GSEA),  a powerful analytical method for interpreting gene expression data by 
focusing on gene sets and shared common biological function119, was performed. 
GSEA reveals several biological pathways in common and notably, endocrine 
pancreas but not exocrine pancreas development pathway was significantly down-
regulated in aldh3a1 mutants (Fig.11). 
 
 
Fig.10 An overview of RNA Sequence Results. 
(A). Results of the quality control in gene expression analysis between aldh3a1-/-  and  aldh3a1+/+  
zebrafish larvae at 48hpf. Principal component 1,2 and 3 are on the axis. The plots showed the wild 
type(n=5) in blue and aldh3a1 mutants(n=6) in green. (B). Volcano plot showed the down-regulated/up-
regulated between aldh3a1-/- and  aldh3a1+/+  zebrafish larvae at 48hpf. 
RNA Sequence was analysed by Carsten Sticht. 
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Fig.11 Endocrine pancreas development pathway but not exocrine pancreas development 
pathway decreased significantly by GSEA analysis. 
(A). Heatmap showed relative mRNA expression in pancreas development between aldh3a1+/+ (n=5) 
and aldh3a1–/– (n=6). Higher and lower expression is displayed in red and blue, respectively. (B). 
Analysis result by GSEA. GESA, gene set enrichment analysis. 
RNA Sequence was analysed by Carsten Sticht. 
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To evaluate whether the change of ins and pancreas dysfunction result in 
hyperglycaemia, whole-body glucose were measured and aldh3a1 mutant larvae 
showed around 40% incremental glucose level at 48hpf (Fig.12A).  After pdx1 
morpholino injection, glucose levels were increased in both genotypes and aldh3a1-/- 
gained around 30% more glucose than aldh3a1+/+ larvae (Fig.12B). Additionally, 
aldh3a1-/- larvae with control morpholino injection showed the same levels of ATP and 
ADP compared to aldh3a1+/+ larvae with pdx1 morpholino injection at 96hpf, while 
achieved significantly lowest ATP and ADP level among all groups with pdx1 
morpholino injection indicating the impaired energy metabolism in aldh3a1 mutants 
and may lead to hyperglycaemia directly(Fig.12 C-D). 
 
Fig.12 Whole body glucose is elevated in aldh3a1-/- zebrafish larvae and enhanced by pdx1 
morpholino injection. Aldh3a1-/- larvae achieved significantly lowest ATP and ADP level among 
all groups with pdx1 morpholino injection. 
(A). Whole body glucose in lysed larvae clutches at 48hpf showed increased glucose levels as an 
indicator of impaired glucose homeostasis in aldh3a1-/- larvae. While (B) Pdx1 morpholino injection 
enhanced the impaired glucose homeostasis in aldh3a1-/- larvae at 48 hpf. n = 4-5 clutches with 20-25 
larvae per group. (C-D). ADP and ATP showed similar amount levels in Control-MO injected aldh3a1-/- 
larvae and SB-pdx1-MO injected aldh3a1+/+ larvae, while aldh3a1-/- larvae achieved significantly lowest 
ATP and ADP level among all groups with pdx1 morpholino injection. Derivatives were determined using 
UPLC-FSR in zebrafish lysates at 96 hpf; n = 4-5 clutches with 50 larvae. 6 ng of morpholinos: Control-
MO and SB-pdx1-MO were injected into the one-cell stage of zebrafish embryos respectively. Mean ± 
SD, for statistical analysis one-way ANOVA followed by Sidak‘s multiple comparison test was applied, 
*p<0.05, **p<0.01, ***p<0.001. ADP, adenosine diphosphate; ATP; adenosine triphosphate; Mo, 
morpholino. 
UPLC-FSR analysis was performed by Gernot Poschet/Elena Heidenreich. 
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Lastly, I also analysed aldh3a1 expression under diabetic condition. By pdx1 
morpholino injection in wild type zebrafish embryos, I found increased mRNA levels 
for aldh3a1 among ALDH genes (Fig.13). This result further suggests Aldh3a1 as an 
important regulator of glucose homeostasis in diabetes. 
In conclusion, all the above results indicate the imbalance of glucose homeostasis in 
aldh3a1-/- larvae, which is caused by pancreas dysfunction (see in results 3.4) and 
leads to vasculature alternations afterwards (see in results 3.3). However, why knock 
out of Aldh3a1 in zebrafish can result in pancreas dysfunction remained unknown and 
is therefore further investigated. 
 
Fig.13 Aldh mRNA levels in wild type zebrafish larvae. 
Aldh1a3, aldh1l2, aldh3a1 aldh3b1 mRNA levels were raised and aldh7a1 was decreased significantly 
in zebrafish larvae at 48 hpf after pdx1 morpholino injection. 6 ng of morpholinos: Control-MO and SB-
pdx1-MO were injected into the one-cell stage of zebrafish embryos respectively. Expression of mRNA 
was analyzed by RT-qPCR at 48 hpf and expression was normalized to beta-actin. Values for Control-
MO injected zebrafish larvae were standardized to1; n = 3 clutches with 30 larvae per group; Mean± 
SD, for statistical analysis Student’s t-test was applied, *p<0.05, **p<0.01. Mo, morpholino. 
 
 Detoxification of 4-HNE but not MG is impaired and causes hyperglycaemia in 
Aldh3a1 knock out. 
 
Aldehyde dehydrogenase has a board spectrum of substrates such as acetaldehyde, 
4-HNE and MG72. In addition, our previous study also showed compensatory function 
of ALDH superfamily in glo1 mutants90, which is the main detoxifying enzyme system 
for MG and strongly associated with diabetes and its complications89. Therefore, I 
aimed to explore whether MG is increased after loss of Aldh3a1 and criminal for the 
vascular alternation.  The enzyme activity to detoxify MG and the internal 
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concentrations of MG in zebrafish larvae at 96hpf were determined. Results showed 
the ability to detoxified MG was not changed neither by ALDH nor by Glo1 in aldh3a1 
mutants (Fig.14 A-B). Moreover, the MG level was unaltered between wild type and 
aldh3a1 mutants, which suggest MG is not essential for the observed phenotype after 
Aldh3a1 knock out (Fig.14C). 
 
 
Fig.14 Detoxification of methylglyoxal (MG) is not impaired by Aldh3a1 knock out. 
 Aldh3a1-/- zebrafish larvae showed unaltered ALDH enzyme activity (A), GLO1 enzyme activity(B) when 
MG as substrate measured by spectrophotometric analysis and MG amount(C) determined by LC-
MS/MS at 96 hpf; n = 3 to 6 clutches with 46 to 50 larvae. Mean± SD, for statistical analysis Student’s 
t-test was applied. NS: not significant. MG, methylglyoxal. 
Enzyme-activity assays and MG measurements were performed by Jakob Morgenstern/Tomas Fleming. 
 
 
 
Recent data have shown human ALDH3A1 has high affinity for 4-HNE76 and aldh3a1-
/- zebrafish caused around 30% reduction of ALDH activity when using 4-HNE as 
substrate(see in result 3.1). Thus, internal 4-HNE concentration was measured in 
zebrafish larvae at 96hpf by ELISA and a 60% significant increase in aldh3a1 mutants 
was observed (Fig.15A). Besides, 4-HNE facilitates the formation of 1,4-Michael 
addition adducts primarily with cysteine120 and around 20% reduction of free cysteine 
was observed in aldh3a1-/- larvae at 96hpf (Fig.15B). This suggests more than normal 
amount of cysteine is united with exceeding 4-HNE and cause the reduced free 
cysteine level in aldh3a1 mutants. 
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Fig.15 The amount of 4-HNE increased while cysteine decreased in aldh3a1-/- zebrafish larvae at 
96 hpf. 
Aldh3a1-/- zebrafish larvae showed increased 4-HNE amount measured by ELISA(A) and decreased 
free cysteine(B) determined using UPLC-FSR at 96 hpf; n = 5-7 clutches with 45 to 50 larvae. Mean± 
SD, for statistical analysis Paired samples t-tests was applied. *p<0.05, ***p<0.001.4-HNE, 4-
Hydroxynonenal. 
UPLC-FSR analysis was performed by Gernot Poschet/Elena Heidenreich. 
 
 
To evaluate if the increased 4-HNE level causes the phenotype in aldh3a1-/- larvae, a 
series of 4-HNE incubation assays were performed. 5 µM and 10µM were selected to 
perform the experiments, as they are effective and zebrafish larvae show normal gross 
morphology after incubation. First of all, both 5 µM and 10µM incubation partially 
altered trunk vasculature morphology, led to increased formation of abnormal ISV but 
not hyper branches in Tg(fli1:EGFP) zebrafish larvae at 96hpf (Fig.16). While in hyaloid 
vasculature of zebrafish larvae at 120 hpf, 5µM incubation induced more sprouts and 
10 µM induced both increased IOC diameter and sprouts formation (Fig.17).  
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Fig.16 4-HNE incubation partially alters trunk vasculature morphology, leads to increased 
formation of abnormal ISV in Tg(fli1:EGFP) zebrafish larvae. 
4-HNE incubation partially alters trunk vasculature morphology, leads to increased formation of 
abnormal ISV (white arrows) in Tg(fli1:EGFP) zebrafish larvae at 96hpf. Blank, 5µM and 10µM 4-HNE 
were add to each group respectively and medium was changed every day. (A). Light microscopic images 
showed the gross morphology of zebrafish larvae and black boxes indicate region seen in the confocal 
images. White scale bar = 100 μm, black scale bar =500 μm. (B-C). Quantification of abnormal ISV and 
hyper branches formation; n = 10-12 per group. Mean± SD, for statistical analysis one-way ANOVA 
followed by Sidak‘s multiple comparison test was applied, ****p<0.0001. 
 
All the above results indicate the vasculature alternations after 4-HNE incubation are 
similar to Aldh3a1 knock out. Then, for better understanding if 4-HNE causes 
vasculature alternations via inhibiting the development of pancreas directly, 5 µM and 
10 µM 4-HNE incubation was used in zebrafish pancreas transgenic reporter line. Both 
concentrations caused reduced dimension of the early primary endocrine islet in 
Tg(hb9:GFP) zebrafish larvae(Fig.18) and reduced size of early β cell  mass in 
Tg(ins:nfsB-mCherry) zebrafish larvae at 72hpf(Fig.19), in accordance with the change 
after Aldh3a1 knock down. In the end, ins and pdx1 gene mRNA significantly reduced 
after incubation of both concentrations (Fig.20), which is also in line with both Aldh3a1 
transient knock down and permanent knock out. 
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Fig.17 4-HNE incubation alters hyaloid vasculature morphology, induces increased formation of 
IOC branch diameters and sprouts in Tg(fli1:EGFP) zebrafish larvae. 
4-HNE incubation leads to increased IOC branch diameters (10 µM) and sprouts(5µM and 10 µM) in  
hyaloid vasculature of Tg(fli1:EGFP) zebrafish larvae at 120hpf. Blank, 5µM and 10 µM 4-HNE were 
add to each group respectively and medium was changed every day. (A). Representative hyaloid 
vasculature confocal picture after 4-HNE incubation.  White scale bar = 20 µm. (B-C). Quantification of 
the IOC branch diameters and sprouts, n=10-12 per group. Mean± SD, for statistical analysis one-way 
ANOVA followed by Sidak‘s multiple comparison test was applied, ***p<0.001, ****p<0.0001.  
 
 
Fig.18 Area size of the early primary endocrine islet in Tg(hb9:GFP) zebrafish larvae shows 
reduced dimensions with 4-HNE incubation.  
4-HNE incubation induces reduced dimensions of early primary endocrine islet (5µM and 10 µM) in 
Tg(hb9:GFP) zebrafish larvae at 72hpf. (A). Representative fluorescence microscope pictures of the 
early developing endocrine with 4-HNE incubation. White box indicates the developing pancreas. White 
scale bar = 100 µm, grey scale bar = 50 µm. (B). Quantification of area sizes of the early primary 
endocrine islet. Mean± SD, for statistical analysis one-way ANOVA followed by Sidak‘s multiple 
comparison test was applied, ****p<0.0001. 
 
Overall, this part illuminates the 4-HNE detoxification is impaired after Aldh3a1 knock 
out, and hints increased internal 4-HNE concentration can be a dominated factor for 
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causing pancreas dysfunction, hyperglycaemia and vasculature alternations 
afterwards. 
 
 
Fig.19 Early β cell mass in Tg(ins:nfsB-mCherry) zebrafish larvae shows reduced size with 4-
HNE incubation.  
4-HNE incubation induces reduced trend of β-Cell mass(5µM and 10 µM)  in Tg(ins:nfsB-mCherry) 
zebrafish larvae at 72 hpf. (A). Representative fluorescence microscope pictures of the early β-Cell 
mass in with 4-HNE incubation. White box indicates the β-Cell mass area. White scale bar = 100 µm, 
grey scale bar = 50 µm.  (B). Quantification of area sizes of the β-Cell mass area size. Mean± SD, for 
statistical analysis one-way ANOVA followed by Sidak‘s multiple comparison test was applied, **p<0.01. 
 
 
Fig.20 4-HNE incubation leads to 
the decreased pdx1 and insulin 
mRNA level. 
Ins, insb and pdx1 mRNA expression 
level between wild type zebrafish 
larvae and with 4-HNE incubation at 
48hpf. Expression of mRNA was 
analysed by RT-qPCR normalized to 
b2m. Values for wild type control 
zebrafish larvae were standardized 
to1, n = 3-4 clutches with 30 larvae 
per group. Mean + SD, for statistical 
analysis one-way ANOVA followed 
by Sidak‘s multiple comparison test 
was applied, *p<0.05, **p<0.01.  
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 Overfeeding leads to obesity and alters retina morphology but does not develop 
hyperglycaemia in aldh3a1-/- adult zebrafish. 
Over nutrition is a main reason for developing diabetes and accelerating the 
progression of diabetes complications including diabetic retinopathy121.As zebrafish is 
already an appropriate tool for obesity modelling and  diabetes research122, 
overfeeding experiments were performed according to the established protocol 97 and 
sacrificed after 8-week feeding period. Body and liver weight, postprandial glucose, 
retinal morphology as well as metabolites were examined during the assay. 
After 8-week period feeding, all adult zebrafish gained increased weight. Animals from 
overfeeding group displayed a significantly heavy body weight than normal feeding 
ones, regardless of genotype (Fig.21A). However, the liver weight, liver/body weight 
ratio and 1h postprandial blood glucose did not show difference among each group 
(Fig.21 B-D). 
 
Fig.21 Overfeeding leads to obesity in both aldh3a1+/+ and aldh3a1-/- zebrafish but not developed 
hyperglycaemia. 
(A). After 8-week period feeding, zebrafish in the overfeeding group have gained significantly more 
weight than zebrafish in the normalfeeding group. Weight was measured at the start and at the end of 
the feeding period. (B-C). The weight of liver and the liver/body weight ratio showed no difference among 
each group. (D). 1h postprandial blood glucose levels showed no significant difference between each 
group. n = 3-4 fish per group. Mean ± SD, for statistical analysis one-way ANOVA followed by Sidak‘s 
multiple comparison test was applied, *p<0.05, **p<0.01.NS, not significant; NF, normal feeding; OF, 
overfeeding. 
Blood glucose levels were determined jointly with Haozhe Qi (Ryan). 
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As retina is susceptive to hyperglycaemia and overdoes nutrition, different forms of 
pathologies including neurodegeneration and angiogenesis may happen after the 
damage of small vessels and neurons during  diabetes and obesity 123. The retinae 
were dissected from overfeeding/normalfeeding group and the architecture was 
analysed under confocal microscope by following a published protocol98.In general, 
one retina displays three different vascular parts, including low, middle and high 
density area. Normalfeeding did not affect the structure of retina in each group. 
However, the aldh3a1-/- retinal vasculature showed more interconnections between the 
vascular arcades with significantly increased sprouts and an increased trend of branch 
points after overfeeding (Fig.22). 
 
To assess the metabolic changes after high nutrition intake and whether it is influenced 
by the loss of Aldh3a1, metabolites analyse were performed in adult zebrafish liver 
including amino acids, thiols and adenosines. There is no significant difference of 
amino acids in adult animal livers among each group even after overfeeding (Fig.23). 
In adenosine, nicotinamide adenine dinucleotide phosphate (NADPH) showed 
increased trend in aldh3a1-/- animal with normalfeeding condition. Nevertheless, this 
phenomenon disappeared after overfeeding by the elevation in both groups. Moreover, 
nicotinamide adenine dinucleotide (NADH), total and reduced glutathione (GSH) were 
incremental significantly in wild type and showed increased trend in knockout animal 
liver with overfeeding (Fig.24). Which suggests the increased ROS in animal after 
overload nutrition. 
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Fig.22 Aldh3a1-/- Tg(fli1:EGFP) adult zebrafish exhibit altered morphology of the retinal 
vasculature after overfeeding. 
 (A). Representative confocal scans of high density areas of retinal vasculature (350x350 µm² square 
with contact to the IOC) in aldh3a1+/+ and aldh3a1-/- adult zebrafish with normalfed and overfeeding at 8 
mpf. B. Quantified sample for branch points (white circle) and sprouts (white arrowhead). C. 
Representative picture of adult Tg(fli1:EGFP) zebrafish retinal vasculature showed different areas of 
vessel density (including low, middle, high vessel density areas). (D-E). Quantification of vascular 
parameters in the outer retinal periphery (n = 4 retinae from 3-4 animals per group). Mean± SD, for 
statistical analysis one-way ANOVA followed by Sidak‘s multiple comparison test was applied, *p<0.05, 
**p<0.01.Mpf, month post fertilization. NF, normal feeding; OF, overfeeding. 
Adult zebrafish retinae were prepared jointly with Xiaogang Li. 
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Fig.23 Overfeeding does not alter the amino acid level in adult zebrafish liver. 
(A-B). Amino acids showed no alteration among each group. UPLC-MS was used to determine amino 
acids, thiols and adenosine in adult zebrafish livers after 8-week period normal and overfeeding. N=3-4 
per group; mean ± SD, for statistical analysis one-way ANOVA followed by Sidak‘s multiple comparison 
test was applied. NF, normal feeding; OF, overfeeding. 
UPLC-MS analysis was performed by Gernot Poschet/Elena Heidenreich. 
 
 
In summary, overfeeding leads obesity and alters retina morphology in aldh3a1-/- adult 
zebrafish but the hyperglycaemia showed in Aldh3a1 knockout larvae disappeared in 
adult knockout animal. This may imply the regeneration of pancreas and β cell as a 
self-healing process during the growth to avoid the progression of impairment after 
loss of Aldh3a1. 
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Fig.24 Overfeeding leads to some alterations in adenosines and thiols in adult zebrafish liver. 
A. Total and reduced GSH were increased by overfeeding in both knockout and wildtype animal livers. 
B. NADH increased significantly after overfeeding despite the genotype and NADPH showed an 
increased trend in knockout animal livers. UPLC-FSR was used to determine, thiols and adenosine in 
adult zebrafish livers after 8-week period normal and overfeeding. N=3-4 per group; mean ± SD, for 
statistical analysis one-way ANOVA followed by Sidak‘s multiple comparison test was applied, *p<0.05, 
**p<0.01. GSH, glutathione; NADH, nicotinamide adenine dinucleotide; NADPH, nicotinamide adenine 
dinucleotide phosphate. NF, normal feeding; OF, overfeeding. 
UPLC-FSR analysis was performed by Gernot Poschet/Elena Heidenreich. 
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4 DISSCUSSION 
In this study, the developmental and physiological function of Aldh3a1 enzyme system 
in zebrafish was investigated for the first time. Zebrafish Aldh3a1 knockout model was 
generated and characterized and the main findings are summarized in Fig.25: 1. 
Aldh3a1 enzyme system is comparable to human and mouse by displaying a similar 
sequence and active site. 2. Loss of Aldh3a1 causes decreased ALDH activities but 
healthy gross development in zebrafish. Aldh3a1-/- larvae exhibit abnormal 
angiogenesis in trunk and retina hyaloid vasculature formation and the whole process 
is accelerated via Pdx1 induced hyperglycaemia. 3. Aldh3a1-/- larvae display 
imbalance energy metabolism and moderate hyperglycaemia, which is caused by the 
destruction of pancreas development. 4. Defective 4-HNE detoxification and the 
elevation of internal 4-HNE after Aldh3a1 loss, emphasising 4-HNE as a vital 
intermediate to regulate metabolic diseases via glucose homeostasis. 5. Overfeeding 
leads to the obesity and alters retina vasculature but not develops hyperglycaemia in 
aldh3a1-/- adult zebrafish. 
 
 
Fig.25 Model for the role of the Aldh3a1 in zebrafish. 
In larvae stage, knock out of Aldh3a1 in zebrafish leads to decreased ALDH activity and increased 4-
HNE amount, which destructs the structure of the pancreas and results in hyperglycaemia afterwards. 
Elevated glucose level causes increased angiogenetic formation in trunk and retinal hyaloid vasculature 
and can be enhanced via pdx1 expression silencing. In adult Aldh3a1 knockout zebrafish, overfeeding 
alters retina vasculature but not develops hyperglycaemia. 
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 The Aldh3a1 enzyme system in zebrafish 
 
The ALDH3 superfamily includes enzymes with the capacity to oxidize medium-chain 
aliphatic and aromatic aldehydes, such as peroxidic and fatty aldehydes. In addition, it 
also contains enzymes that have non-catalytic functions, including antioxidant 
functionalities76. ALDH3A1(Aldh3a1), one of the necessary members for aldehydes 
oxidation as well as being involved in several metabolisms, including but not limited to 
corticosteroids, biogenic amines, neurotransmitters, and lipid peroxidation, exists in 
zebrafish and almost every mammal but is missing in birds74. Several types of epithelial 
tissues in mammals, especially exposing to environmental stimulation continually, 
such as corneal epithelium, express ALDH3A1(Aldh3a1) at high levels. Its abundance 
in such tissues is perceived to help to maintain cellular homeostasis under oxidative 
stress. Metabolic as well as non-metabolic roles for ALDH3A1(Aldh3a1) have been 
associated with its mediated resistance to cellular oxidative stress124. 
 
The protein sequence alignment of ALDH3A1(Aldh3a1) displayed a comparable signal 
peptide sequence and identical enzyme active sites (glutamic acid and cysteine) 
among zebrafish, human and mouse. This suggests zebrafish Aldh3a1 may behave 
similarly as mammals in both metabolic and non-metabolic roles while also 
emphasizing Aldh3a1 knockout zebrafish as a novel and appropriate model for human 
ALDH3A1 physiological and pathological functional study.  
 
To get a basic understanding of Aldh3a1 character, a property of this enzyme 
distribution in zebrafish regarding the time and destination needs to be identified at 
first. So far, as the commercial antibody for zebrafish Aldh3a1 is not generated yet, 
qPCR-based mRNA expression of aldh3a1 was performed instead. I found that the 
expression of aldh3a1 is increased with developmental age in larvae, expressed in all 
adult organs and mostly in brain and eyes. Similar expression patterns were identified 
in mammals that ALDH3A1 (Aldh3a1) is highly expressed in the cornea125, and in 
mouse, Aldh3a1 is also sufficient in lens and brain 126, 127. Generally, the expression of 
zebrafish aldh3a1 mRNA implies its essential role during growth, especially in eyes. 
 
To sum, the data indicate that the Aldh3a1 enzyme system in zebrafish highly 
resembles the one in humans, by displaying similar enzyme characteristics and 
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expression pattern. Therefore, zebrafish is a suitable model to study this enzyme 
system in vivo. 
 
 Aldh3a1-/-larvae exhibit abnormal angiogenesis in the trunk and retinal hyaloid 
vasculature, which was accelerated by hyperglycaemia. 
 
Up to date, no Aldh3a1 mutant was described in zebrafish. Yet, a study in mice showed 
that ALDH3A1-deficient mice developed cataracts because of the proteasome 
inhibition by lipid peroxidation86, but additional phenotypes in these mice have not been 
reported. Therefore, I have generated Aldh3a1 knockout zebrafish for the first time by 
using CRISPR-Cas9 technology leading to an 11-base pair insertion. Amino sequence 
analysis of the 11-base pair aldh3a1 mutant suggests the knock out by leading a Stop-
codon in exon 2. Due to the lack of a specific commercial antibody for this zebrafish 
enzyme and own unsuccessful attempts to generate a new specific antibody together 
with the German Cancer Research Center (DKFZ) antibody core facility, I was not able 
to prove the knock out by western blot. Instead, acetaldehyde, one of the most common 
aldehydes and 4-HNE, a specific aldehyde showing high affinity with 
ALDH3A1(Aldh3a1), were used for ALDH activity measurement. Both acetaldehyde-
dependent and 4-HNE-dependent ALDH activity decreased significantly in aldh3a1 
mutants, which confirms the knock out while also verifies the essential role of Aldh3a1 
for aldehydes detoxifying among ALDH superfamily. 
 
Angiogenesis leads to the formation of the ISVs of the trunk during zebrafish 
development128. Although our study showed normal gross morphology of zebrafish 
larvae despite the genotype and aldh3a1-/- zebrafish larvae demonstrated no difference 
in hyper branches. However, a slight increase in abnormal ISVs was observed in 
aldh3a1 mutant larvae at 96hpf. ISV development starts at 22hpf with the primary wave 
of endothelial cell sprouting and formation of the segmental artery (SA) originating from 
the dorsal aorta. Ten hours later, segmental vein(SV) is formed by a second 
endothelial cell wave originating from the common cardinal vein  129. During the whole 
process, signalling through the VEGF/VEGF receptor (VEGFR) pathway is the driver 
for controlling physiological development and also in pathological conditions. Vegfa 
controls the formation of SA by primary angiogenesis wave, and Vegfc is essential for 
secondary angiogenesis, giving rise to SV and lymphatics130. Besides, Bower et al. 
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found that Vegfd plays context-specific and compensatory roles during both blood 
vessel angiogenesis and lymphangiogenesis, rather than being dispensable as a 
thought in the previous study131.Based on our RNA-Seq result, vegfd but not vegfa or 
vegfc altered in aldh3a1 knockout mutants, indicating Vegfd may be the potential 
factors leading to abnormal formation of ISVs.  
By using pdx1 morpholino injection leading to hyperglycaemia and mimicking diabetic 
condition, I observed enhanced vasculature alternations with both increased hyper 
branches and abnormal ISV numbers in aldh3a1 mutants. As mentioned before, VEGF 
is the most crucial mediator for angiogenesis, the question, how could the high glucose 
level induce the angiogenesis and via VEGF directly or indirectly, draws our attention. 
 
Angiogenesis is controlled by both pro- and anti-angiogenic factors and an imbalance 
can result in the activation. Generally, VEGF expression is produced mainly by hypoxia 
via the activation of hypoxia-inducible transcription factor 1(HIF1) 132. Besides, several 
studies showed glucose itself leads to the increase of VEGF expression, including but 
not limited to retinal endothelial cells, epithelial cells, Müller cells, vascular smooth 
muscle cells and also in zebrafish larvae96, 133-136. One of the mechanisms is activation 
of PKC pathway by raised glucose, which induces the expression of VEGF in human 
vascular smooth muscle cells137. Additionally, increased ROS and ROS release 
orchestrated during hyperglycaemia by polyol and PKC pathway can stimulat VEGF 
signalling and drive the angiogenic process. In endothelial cells, NADPH oxidase 
(NOX) 4 derived H2O2 in part activates Nox2 to increase mitochondria production via 
elevated S36 phosphorylation of p66Shc, therefore enhancing VEGFR2 signalling and 
angiogenesis 138. 
 
Several studies already explored the effects of hyperglycaemia in zebrafish retina 
hyaloid vasculature network. Treating with 130mM glucose from 3 days to 6 days after 
post fertilization (dpf), zebrafish larvae exhibited formation of dilated hyaloid-retinal 
vessels accompanied by disrupted tight junction proteins. All these alternations were 
related to the elevation of Nitrate Oxygen (NO) production and increased vegfa mRNA 
expression96. Incubation with 4% and 5% D-Glucose in a pulsatile manner from 3hpf 
to 5dpf, Singh et al. found numerous ocular dysfunctions in zebrafish larvae, which is 
associated with altered retinal cell layer thickness, increased presence of 
macrophages, and decreased number of Müller glial and retinal ganglion cells following 
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high-glucose exposure139. However, all the above studies showed the retinal 
alternations by external glucose intervention. Whether the induced angiogenic 
phenotype of the retina is driven by the internal hyperglycaemia or other metabolomics 
alternation or just the “unspecific feedback reaction” to the extremely high amount of 
external glucose even just the change of osmotic pressure, remains unknown.  
 
Differently, our study focuses on the hyaloid vasculature while also the connection of 
internal metabolic change after the gene knock out. Aldh3a1 mutants displayed the 
widen branches in retina hyaloid vasculature network, which drives our attention, if the 
alternations related to the glucose level in aldh3a1 mutants? Also, pdx1 knockout 
zebrafish model was successfully generated, and the knock down of Pdx1 is confirmed 
as an effective tool to study the influence of short-term high internal sugar level on 
retina vasculature92. The phenotype is enhanced with both widen IOC branch 
diameters and increased number of sprouts aggregately in aldh3a1-/- compared to 
aldh3a1+/+ larvae after pdx1 morpholino injection. Which further emphasises the 
question, if hyperglycaemia plays an essential role in the alternation after the loss of 
Aldh3a1, and can be activated via decreased Pdx1 expression as a cascade reaction 
to accelerate the whole angiogenetic process? 
 Aldh3a1-/- larvae display imbalance energy metabolism and moderate 
hyperglycaemia, which is caused by the destruction of pancreas development. 
 
To address the question: if hyperglycaemia plays an essential role in the alternation 
after the loss of Aldh3a1, and can be activated via decreased Pdx1 expression, body 
glucose was measured in the zebrafish larvae, and our results showed aldh3a1 
mutants exerted hyperglycaemia by 40% increase of the whole-body glucose. 
Furthermore, glucose levels were increased in both genotypes after a pdx1 morpholino 
injection, and interestingly aldh3a1-/- mutants gained around 30% more glucose than 
aldh3a1+/+ larvae. Which confirms, hyperglycaemia due to the Aldh3a1 loss results in 
the primary moderate vascular alternations, and decreased Pdx1 expression 
accelerate the pathological angiogenetic process by further glucose elevation. 
 
During the first couple of days of the development, zebrafish embryos/larvae utilize 
energy and nutrition from the yolk sac until they are feeding from external food sources 
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starting at around 5dpf-6dpf140. Therefore, the direct link for hyperglycaemia should be 
a series of energy metabolisms regulation by itself.   
ATP is a complex organic chemical that provides energy to drive many processes in 
living cells, such as muscle contraction, nerve impulse propagation and mass of 
chemical/bio synthesis141. A number of distinct cellular processes can produce ATP, 
and three main pathways in eukaryotes are 1). glycolysis, 2). the tricarboxylic acid 
(TCA) cycle and oxidative phosphorylation, and 3). beta-oxidation. In addition, it 
converts to ADP or AMP via dephosphorylation when consuming in metabolic process. 
The dynamic equilibrium of the ATP/ADP cycle is the basement of several biomedical 
activities, including intracellular signalling, DNA and RNA synthesis and amino acid 
activation in protein synthesis142. 
ATP/ADP ratio, as the cellular “energy state”, is responsible for coupling glucose 
stimulus to insulin secretion143. In physiological condition, the elevation of glucose level 
can result in increased glycolysis and thereby input reducing equivalents into both the 
citric acid cycle through pyruvate dehydrogenase (PDH) and respiratory chain through 
the glycerol phosphate shuttle. The influx of reducing equivalents is “greater" than what 
is needed for ATP synthesis, hence, leads to a reduction of the intra mitochondrial 
NAD pool and an increased ATP/ADP ratio in "energy state" 143. However, decreased 
ATP amount and lower ATP/ADP ratio is measured in aldh3a1 mutants after pdx1 
morpholino injection compared to wild type, suggesting the impaired metabolomic 
energy status to glucose intolerance after Aldh3a1 knock out. Patterson et al. found 
that Mitochondrial pyruvate carrier 1 (Mpc1) and Mitochondrial pyruvate carrier 1 
(Mpc2) are essential for ATP-regulated potassium (KATP) channel pathways of insulin 
secretion regulation in clonal 832/13 β cells as well as mammal islets. Inhibition of the 
MPC by both pharmacological inhibitors and siRNA-mediated knockdown blocked the 
insulin secretion through ATP/ADP ratio regulation and resulted in impaired glucose 
tolerance144 Also significantly reduced mitochondrial pyruvate carriers (mpc1 and 
mpc2) mRNA expression was observed in aldh3a1 mutants, which may be the directly 
reason lead to energy metabolism imbalance and hyperglycaemia. 
 
Until now, it was identified that glucose metabolism is impaired in aldh3a1 mutants, 
which may be linked to insufficient insulin secretion on account of reduced ins mRNA 
level. Further investigation concerning its source, pancreas and β Cell, would be 
necessary. Keen interest is raised, particularly in understanding pancreas 
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development as it goes hand in hand to different forms of diagnoses and therapies for 
diabetes. Apart from Pdx1, the most crucial transcription factor gene for pancreatic 
development, the Hb9(Mnx1) gene encodes a homeobox transcription factor in 
vertebrates that has conserved functions in motoneuron differentiation and pancreas 
development145. In zebrafish, hb9 plays an essential role in zebrafish endocrine cell 
fate decisions40 and is required and sufficient for regulating expression in β cells prior 
to the onset of insulin expression146. By using zebrafish as a visual model for pancreas 
morphology study, a combination of Aldh3a1 knockout and knockdown strategies 
identified a decreased pancreatic size in Tg(hb9:GFP) and reduced β Cell mass 
dimension in Tg(ins:nfsB-mCherry) zebrafish larvae, which indicates the destruction of 
the pancreas before decreased insulin secretion. Besides, Rna-Seq and qPCR-based 
mRNA expression results also showed: the expression of several genes involved into 
endocrine pancreas development was decreased in aldh3a1 mutants, including but not 
limited to pdx1, hb9, sox9b, rfx3, notch2, wnt5b, isl2b, which hints the dysfunctional 
pancreas may result from the insufficiency of several transcription factors, such as Hb9 
and Pdx1.  
 
According to all the above data, we suppose two mechanisms which links to the 
insufficient insulin expression in aldh3a1 mutants: 1) the imbalance energy metabolism 
including impaired ATP/ADP signalling pathway, which can be related to high sugar 
level directly in aldh3a1 mutant larvae before external food intake. 2) the destruction 
of the early pancreas because of the dysfunction of several transcription factors such 
as Hb9 and Pdx1, which may be the initiative cause Nevertheless, how could the 
missing of aldh3a1, one enzyme gene, leading to these following changes to 
hyperglycaemia at the end? 
 
 Defective 4-HNE detoxification and increased internal 4-HNE concentration 
regulate metabolic diseases via glucose homeostasis after Aldh3a1 loss.  
 
MG is a reactive organic compound involved in the biology of diabetes. Due to the 
increased blood sugar level, elevated MG levels can be observed in diabetes and 
thereby participates in the formation of AGEs147. In zebrafish larvae, one study 
revealed that MG induced pathological angiogenesis in the trunk vasculature, due to 
the activation of the VEGF/VEGFR2 signalling cascade148. Besides, a permanent 
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knock out of Glo1 in zebrafish, the primary MG detoxifying system, led to a two-fold 
increase in ALDH activity and qPCR-based expression data identified increased 
mRNA levels of aldh3a1 in the glo1 mutants90. All of the above hints suggest Aldh3a1 
as an alternative compensatory enzyme for the MG detoxification. The increased MG 
may cause hyperglycaemia and related phenotype after Aldh3a1 loss. However, 
neither the enzyme activity to detoxify MG nor the internal concentration of MG was 
changed in aldh3a1 mutants.  
 
4-HNE, one of the most prominent lipid peroxidation specific aldehydes, has shown a 
high affinity with ALDH3A1 in several studies. Treating with H2O2, Natalie et al. found 
increased 4-HNE adducted proteins in a rabbit corneal fibroblastic cell line (TRK43) 
without human ALDH3A1 transfection compared to ALDH3A1-TRK43 cells after the 
treatment of H2O2  88. Aglaia et al. showed that human corneal epithelial cell line (HCE) 
transfected with ALDH3A1 were more resistant to UV- and 4-HNE-induced cytotoxicity 
than mock-transfected cells149. M Hlaváčová et al. demonstrated increased plasma 
level of 4-HNE accompanied by decreased Aldh3a1 gene expression in the liver in 
Wistar rats applied with conventional doxorubicin150. By measuring the 4-HNE 
concentration and ALDH activity in vivo, I identified the internal increased 4-HNE 
concentration and decreased ability to detoxify 4-HNE in aldh3a1 knockout zebrafish 
for the first time. 
 
The detrimental and cytotoxic effects of 4-HNE have been described in myriad tissues, 
organs and links to the pathological process. Also, pancreas and β cells are 
susceptible to the influence of 4-HNE. One study found a significant increase in 
interleukin-1β expression and 4-HNE formation in cat islet after a period of 
hyperglycaemia and obesity, suggested the elevation of inflammation and oxidative 
marker occurs very early during the diabetes development151. The destruction of rat 
pancreatic islet β cell by cytokine combination of IL-lβ, TNFα, and IFNγ was closely 
associated with aldehyde production, including 4-HNE and MDA 152. Moreover, high 
levels of 4-HNE can induce massive β cell death. Rat pancreas islets treated with 
increasing 4-HNE concentration showed a dose-dependent decrease of glucose-
stimulated insulin secretion 153.In acute pancreatitis rats, pancreatic 4-HNE levels were 
increased by 300%, accompanied by the 50% reduction of glutathione peroxidase 
(GPx)154. 
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The general role of 4-HNE involved in β cell dysfunction can be described in two 
signalling mechanisms. First, via activating or inhibitory interactions with receptors, key 
signalling molecules, enzymes and other macromolecules such as mitochondrial, TCA 
cycle enzymes and lipoproteins68. Once the capacity of 4-HNE is exceeded, through 
increased lipid peroxidation and oxidative stress, it leads to structural and 
conformational modification of the macromolecules and ultimately attributes to the β 
cell dysfunction and failure. 
The other role is that 4-HNE can regulate the expression of several major transcription 
factors. For instance, 4-HNE activated the pro-inflammatory transcription factor 
(nuclear factor kappa-light-chain-enhancer of activated B cells) NF-κB155, leading to 
deteriorating responses including hyperglycaemia. However, it remains unclear which 
transcription factor is influenced by high 4-HNE amounts during pancreas destruction. 
We identified that 4-HNE induced a similar phenotypes as seen in aldh3a1 mutants 
when added on wild type larvae, with the destructed pancreas and decreased mRNA 
expression of ins and also of pdx1. However, potential transcription factors which can 
be targeted directly needs more exploration in the future. 
Furthermore, 4-HNE treated wild type larvae exhibited altered angiogenesis in the 
retinal hyaloid vasculature network with both increased IOC diameters and sprouts 
formation. This may result from the double effects: 4-HNE induced hyperglycaemia 
and 4-HNE induced oxidative stress, which can activate the WNT pathway and cause 
diseases in retina directly 156. Zhou et al. showed increased 4-HNE level in the retina 
of diabetic rats, accompanied with increased phosphorylated and total LDL receptor-
related protein (LRP) 6, cytosolic β-catenin and connective tissue growth factor 
(CTGF), which can be attenuated by N-acetyl-cysteine (NAC), an antioxidant as well 
as a thiol-protective agent 156. While retinal pigment epithelial cells and retinal capillary 
endothelial cells also exhibited activated WNT pathway after 4-HNE intervention in 
vitro, by increasing LRP6, cytosolic β-catenin and CTGF expression level156. 
 
How could 4-HNE influence energy metabolism is still under investigation and several 
studies already illuminated the role of 4-HNE in mitochondria. Mitochondria are 
essential for the life of eukaryotic cells because of the critical functions including ATP 
generation and TCA metabolism, and these functions are tightly regulated by 
mitochondrial lipids such as cardiolipin (CL) and 4-HNE 157. Increased oxidative stress 
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caused by exceed ROS may lead to the accumulation of lipid peroxidation, and these 
reactive lipid species cause mtDNA mutation, dysfunctional mitochondrial membrane, 
and protein modification. All these effects can lead to mitochondrial dysfunction and 
further exacerbate the ROS generation and oxidative stress. Moreover, the elevation 
of oxidative stress has been closely associated with insulin resistance and diabetes158. 
ROS activate mitochondrial uncoupling protein 2(UCP2)  via Peroxidation of 
mitochondrial membrane phospholipids, can result in reduced ATP synthesis and 
pancreatic β cell dysfunction159. Decreased ATP level was displayed in aldh3a1 
mutants and after pdx1 morpholino injection, which may be related to 4-HNE induced 
mitochondria dysfunction and further lead to reduced insulin expression. 
 
To sum, I identified a defective 4-HNE detoxification system and increased internal 4-
HNE concentration in aldh3a1 mutants. Increased 4-HNE leads to hyperglycaemia by 
the destruction of the pancreas with both β cell mass reduction and β cell dysfunction, 
which may be regulated by the general role of increased oxidative stress in the 
mitochondrial and specific way of the inhibition of several pancreas transcription 
factors. 
 Overfeeding induced obesity alters retina morphology in aldh3a1-/- adult 
zebrafish. 
 
High nutrition intake is one of the main reasons for developing diabetes and 
accelerating the progression of diabetes complications, including diabetic 
retinopathy121. To assess the effects of Aldh3a1 loss in adult fish, overfeeding 
experiments were performed. Animals from overfeeding group displayed a significantly 
heavier bodyweight than normal feeding ones, regardless of genotype. However, 
hyperglycaemia as observed in aldh3a1 mutant larvae did not continue into adulthood. 
 
The zebrafish pancreas shares conserved functions with the mammal pancreas40. As 
the regenerative capacity of mammalian β cells is restricted, loss and dysfunction of β 
cells can result in diabetes. In contrast to mammals, zebrafish can regenerate 
functional pancreatic β cells throughout their whole life160. Several studies showed α 
cells’ potential contribution to β cell regeneration as well as neogenesis; Also, 
centroacinar cells, which are defined as specialized ductal epithelial cells located at 
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the ends of ducts within the acinar lumen, can form new endocrine cells after β cell 
ablation or partial pancreatectomy 52, 53. 
This suggests that the recovery of normal glucose level in adult fish after Aldh3a1 loss 
results from the regeneration of pancreas and β cell as self-healing during the growth 
to avoid the progression of impairment. Anderson et al. demonstrated adenosine 
agonist NECA can increase β cell proliferation via acting the adenosine receptor A2aa, 
and promote the restoration of normal glucose level in zebrafish larvae [51], which 
suggests an evolutionarily conserved role for adenosine in β cell regeneration. 
Similarly, the significantly reduced adenosine amount in aldh3a1-/- larvae showed no 
difference in adult zebrafish regarding the genotype and feeding method, indicating the 
regained ability of β cell proliferation in aldh3a1-/- adult zebrafish.   
 
Notably, aldh3a1-/- adult zebrafish after overfeeding displayed angiogenetic retinal 
vasculature, which may be a “memory effect” of high glucose levels since the larva 
state139 but not induced by hyperglycaemia in the adult stage139. Besides, overnutrition 
can lead to exceed-burden 4-HNE in aldh3a1 adult mutants on account of 
dysfunctional detoxifying ability, which may further aggravate the phenotype via 
oxidative stress. Detailed mechanisms are necessary to be studied in the future. 
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SUMMARY 
Diabetes mellitus is a global disease with increasing prevalence worldwide. Long-
standing diabetes mellitus leads to various microvascular, including diabetic 
nephropathy, neuropathy, retinopathy, cardiomyopathy etc, and several 
macrovascular complications such as coronary heart disease and stroke. In almost all 
high-income countries, diabetes is a leading cause of cardiovascular disease, 
blindness, kidney failure, and lower limb amputation. The treatment of diabetes and its 
complications results in enormous health expenditure all over the world. 
 
The increased formation of methylglyoxal (MG) under hyperglycaemia is associated 
with the development of microvascular complications in patients with diabetes. 
However, in zebrafish, a permanent knock out of glyoxalase 1(Glo1), the central MG 
detoxifying system, only led to a two-fold elevation of endogenous MG levels. 
Importantly, a two-fold increase in aldehyde dehydrogenases (ALDH) activity, a group 
of enzymes which catalyse the oxidation of aldehydes, was observed. Furthermore, 
qPCR-based expression data identified increased mRNA levels of aldh3a1 in the glo1 
mutants suggesting Aldh3a1 as an alternative protein for the detoxification of reactive 
metabolites. Thus, this project aimed to analyse aldh3a1 mutant zebrafish on its 
function to potentially compensate for the loss of Glo1 in development and disease. 
 
By using CRISPR/CAS9 technology, I generated Aldh3a1 knockout model in zebrafish. 
A series of experiments were performed regarding the function and morphology of 
pancreas, vasculature, glucose homeostasis and metabolism after Aldh3a1 loss.  The 
main findings of this dissertation are: Aldh3a1-/- larvae exhibit impaired 4-
Hydroxynonenal (4-HNE) detoxification ability and increased internal 4-HNE 
concentration, which destructs the pancreas development via β cell mass reduction 
and dysfunction and leads to hyperglycaemia. Impaired glucose homeostasis causes 
abnormal angiogenesis in trunk and retina hyaloid vasculature formation and can be 
further enhanced via down-regulated pdx1 expression.  
 
Although this study successfully linked a loss of Aldh3a1 to an elevation of 4-HNE to 
impaired glucose homeostasis, there are some limitations. First, due to the lack of 
specific and commercial antibodies for zebrafish Aldh3a1, to confirm the Aldh3a1 
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knockout in zebrafish by protein level is unavailable. Second, as aldh3a1 mutants in 
zebrafish pancreas transgenic reporter line have not been generated yet, we cannot 
perform pancreas morphology study in knockout models directly. Additionally, our 
conclusion on how 4-HNE regulates pancreas and β cell morphology, as well as 
function, mostly are based on the qPCR-based mRNA expression data in vivo. It would 
be interesting to explore the potential pathways based on the alterations of protein 
levels. At last, in order to test the primary hypothesis if Aldh3a1 can compensate after 
Glo1 loss, the generation of glo1/aldh3a1 double knockout mutants seems necessary 
in the future. 
 
Overall, this dissertation provided patent evidence for the contribution of deficient 4-
HNE detoxification and subsequent increased 4-HNE concentration to the 
development of hyperglycaemia via pancreas dysfunction in aldh3a1 mutants, as a 
novel direction for future research regarding diabetic pathophysiology and therapy. 
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